Robust estimation of systolic time intervals using ballistocardiogram and seismocardiogram signals by Ashouri, Hazar
 
ROBUST ESTIMATION OF SYSTOLIC TIME INTERVALS USING 



























In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy  
in  












COPYRIGHT © 2018 BY HAZAR ASHOURI 
ROBUST ESTIMATION OF SYSTOLIC TIME INTERVALS USING 




























Dr. Omer T. Inan, Advisor 
School of Electrical and Computer 
Engineering 
Georgia Institute of Technology 
 Dr. Amit Shah 





Dr. Pamela T. Bhatti  
School of Electrical and Computer 
Engineering  
Georgia Institute of Technology 
 Dr. Mozziyar Etemadi 





Dr. David V. Anderson 
School of Electrical and Computer 
Engineering 
Georgia Institute of Technology 
 
   









To my parents, Maan Ashouri and Hala Haidar, 





Many people were essential to the completion of this thesis either on a professional 
or a personal level, or both. I would like to dedicate this section to acknowledging the 
contributions of these people. 
I would like to start by thanking my advisor, Professor Omer Inan. I got introduced 
to Prof. Inan almost a year after starting my graduate studies in Georgia Tech. Within a 
month, it was clear to me that I would not find a better advisor. Little did I know back then 
that this would be one of the best decisions I have ever made. Honestly, I do not think I 
would have been able to continue with a Ph.D. had I not been working with him. He was 
always there to provide guidance and support. I remember going into many of our meetings 
thinking that I have hit a dead-end, but I have always left those meetings with a new 
prospective and excitement to try new ideas. He was also very supportive of my 
professional plans and even helped me accomplish them more than once. I am very grateful 
for him and will never forget the role he played in my life. 
I would also like to thank Dr. Pamela Bhatti, Dr. David Anderson, Dr. Mozziyar 
Etemadi and Dr. Amit Shah for taking the time to be in my dissertation committee. They 
provided me with very insightful feedback regarding my research and the completion of 
my Ph.D. 
I was fortunate to work alongside smart and friendly labmates. I would like to thank 
all my collegues in Inan Research Lab for their help when I needed it and their constuctive 
feedback on my proposal and dissertation: Dr. Sinan Hersek, Dr. Abdul Qadir Javaid, Dr. 
Hakan Toreyin, Dr. Ozan Bicen, Dr. Maziyar Baran Pouyan, Oludotun Ode, Andrew 
 v 
Carek, Caitlin Teague, Nick Bolus, Samer Mabrouk, Mobashir Shandhi, Nil Gurel, Hyeon 
Ki Jeong, Daniel Whittingslow, Beren Semiz, Venu Ganti, Heywon Jung, and Lara 
Orlandic. Specifically, I would like to thank Dr. Abdul Qadir Javaid with whom I 
collaborated heavily in the early stages of my research and Dr. Sinan Hersek who helped 
me greatly throughout my research and mostly in its later stages. I would also like to thank 
Andrew Carek who made data collection fun during our collaboration, Nick Bolus who 
took the time to teach me how to use the 3D printer, and Lara Orlandic who helped me find 
and collect data from human subjects on my first study. Finally, I would like to thank Dr. 
Hakan Toreyin and Oludotun Ode who, in addition to Dr. Javaid, were the first people I 
work with in the lab and published with them the first conference paper related to my 
research. 
I came to Atlanta having one acquaintance and no friends. Today, I have a group of 
friends that I consider family. They turned Atlanta into home to me. My friends, Leya 
Hojeij, Norah Essali, Sinan Hersek, Nour Deen Alnoury, Amr Shehadeh, Ayda Sawaf , 
Sara Al Moukadem and Leen Rmeih, I could not have done it without you. Those people 
were my support system and each one of them changed me into a better person.  
Leya is the purest soul I met in my life. The unconditional love she had for every one 
of us cannot be matched. She always went the extra mile to make people around her happy 
even at her own expense. Leya passed away almost two years ago, but I know that she is 
watching over me and I want her to know that she was, and will always be, part of me. 
Norah is simply my soul mate. She is the sister that I never had. She knows exactly 
what to say in any situation and has a big heart that never judges but always supports. I 
 vi 
cannot recall a happy moment for me in Atlanta that Norah was not part of or a sad time 
that Norah did not help me get through. Even after she moved to Augusta , to pursue her 
residency in psychiatry, our friendship never changed and it never will.  
There are certain people that change the course of your life, Sinan was one of those 
people for me. If it was not for Sinan, I would not have met my advisor, prof. Omer Inan, 
and perhaps, would not have been able to go through the Ph.D. He is my lab mate, my best 
friend, my lunch buddy and my neighbor. I will always be grateful to him. 
On the long tiring work days, the phone call from Nour at the end of the day was 
always something to look forward to. It was always helpful for me to bounce ideas with 
him and hear his point of view, which was different than mine most of the times. I value 
his opinion greatly and he definitely influenced many of my decisions and actions. Our 
friendship has and will continue to withstand any challenge and I am lucky to have that. 
Amr was the only person that I knew when I came to Atlanta as we both went to the 
same highschool in Damascus, Syria. If it was not for him, I might have not met the other 
amazing people mentioned here. He quickly went from being just an acquaintance to 
becoming one of the closest people to me. Whenever I am down and in need for a good 
laugh, I know that he is the one I should go to.  
We usually look up to people older than us, but I look up to Ayda even though she is 
two years younger than me. I met Ayda in Georgia Tech and we became close friends in a 
short period of time. She graduated and moved back to Dubai two years ago, yet our 
friendship only got closer despite the distance. I can say, without hesitation, that Ayda, 
 vii 
through her advice and support, is the person that helped me the most in achieving my 
professional life goals post PhD. For that, I will always be indebted to her.  
It was unfortunate that I did not get to meet Sara during my undergraduate studies, 
even though we both went to the same school in Beirut, Lebanon. However, my luck turned 
when I got a second chance at that by meeting her here in Atlanta, only to wish I had known 
her from before. Her uplifting attitude, warm smile, and encouraging words were always a 
source of comfort whenever the PhD life seemed to get daunting.  
I cannot recall a time that I needed Leen’s help and she was not there for me. She is 
someone I can always count on. Leen taught me to be kind to people yet fearless in going 
after what I want. Knowing that she is in Atlanta, long term, gives me a sense of comfort 
and relief, that no matter what, I will always have family in here.  
Lastly, but most importantly, I would like to  express my deepest gratitude for my 
family; my dad, Maan Ashouri, my mom, Hala Haidar, and my brother, Fahmi Ashouri. 
Fahmi has and will always be the closest person to my heart. I am proud of him and I look 
forward to all the amazing things he will accomplish. My parents always supported me at 
every turn, from backing me up with my decision to do my undergraduate studies outside 
Syria, at the American University of Beirut, to encouraging me to come to the States to 
pursue my Ph.D., even though it meant being away from them, again. If it was not for their 
unconditional love, trust, sacrifice, and support, I would not even dream of being where I 
am today. Nothing I ever say or do can do them justice. I feel extremely grateful and so 
fortunate to have such incredible parents to look up to. You two are my role models and I 
wish I can, one day, be half the person either of you are. 
 viii 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES xi 
LIST OF FIGURES xii 
SUMMARY  xvi 
CHAPTER 1. Introduction 1 
1.1 Motivation 1 
1.2 Major Contributions of this Work 8 
1.3 Thesis Organization 10 
CHAPTER 2. Unobtrusive Estimation of Cardiac Contractility and Stroke 
Volume Changes Using Ballistocardiography measurements on a high bandwidth 
force plate   12 
2.1 Introduction 12 
2.2 Methods 12 
2.2.1 Protocol 12 
2.2.2 Hardware Design 13 
2.2.3 Data Processing 14 
2.2.4 Feature Extraction 15 
2.2.5 Correlation at Rest 16 
2.2.6 Correlation during Exercise Recovery 17 
2.2.7 Estimating Relative Changes in Stroke Volume 17 
2.2.8 Signal-to-Noise Ratio Calculations 18 
2.3 Results and Discussions 19 
2.3.1 RI and PEP Correlation for Scale and Force Plate BCG during Rest 19 
2.3.2  RI and PEP Correlation for Head-to-Foot Force Plate BCG during Recovery 20 
2.3.3 Stroke Volume Estimation from Head-to-Foot Force Plate BCG during 
Recovery 21 
2.3.4 Signal-to-Noise Ratio Comparison for Scale BCG and Force Plate Head-to-
Foot BCG 24 
2.4 Conclusions 27 
CHAPTER 3. Classification of Wearable Seismocardiogram Sensor Positioning 
for Robust Estimation of the Pre-Ejection Period in Unsupervised Settings 29 
 ix 
3.1 Introduction 29 
3.2 Methods 30 
3.2.1 Protocol 31 
3.2.2 Hardware Design 31 
3.2.3 Data Processing 32 
3.2.4 Feature Extraction 32 
3.2.5 Correlation During Rest and Exercise Recovery 34 
3.2.6 Classification of Different Positions of Accelerometers 35 
3.3 Results and Discussions 39 
3.3.1 PEP and R-AO Correlation Results for SCG from Different Sensor Positions 39 
3.3.2 Classification Results 41 
3.4 Conclusions 44 
CHAPTER 4. Universal Pre-Ejection Period Estimation using 
Seismocardiography: Quantifying the Effects of Sensor Placement and Regression 
Algorithms   46 
4.1 Introduction 46 
4.2 Methods 47 
4.2.1 Protocol 47 
4.2.2 Hardware and Data processing 48 
4.2.3 Feature Extraction 50 
4.2.4 Regression Model 51 
4.2.5 SCG Sensor Location Comparison 54 
4.2.6 Rigid vs. Flexible Interfacing Material Between the SCG Sensor and     
Sternum 55 
4.2.7 Feature Importance Evaluation 55 
4.2.8 Comparing Different Regression Techniques 56 
4.2.9 Evaluating the Effect of XGBoost Hyperparameters 58 
4.2.10 Statistical Analysis 59 
4.3 Results 60 
4.3.1 Comparison of Different Sensor Locations 60 
4.3.2 Comparison of Different Sensor Interfacing Material 62 
4.3.3 Comparison of Different Regressors 64 
4.3.4 Effect of XGBoost Hyperparameters 65 
 x 
4.4 Discussion 66 
4.5 Conclusions and Future Work 69 
CHAPTER 5. Conclusion and future direction 71 
5.1 Conclusion 71 
5.2 Future Directions 72 
REFERENCES  74 
 
 xi 
LIST OF TABLES 
Table 1 Comparison of several studies on non-invasive cardiac output 
measurement for exercise and exercise recovery (healthy subjects). 
23 
Table 2 Per subject errors in ∆SV estimation. 24 
Table 3 Per subject SNR calculations for scale and force plate BCG. 24 
Table 4 Best features in terms of information gain 36 
Table 5 The average correlation coefficient (r) obtained from linear, quadratic, 
and cubic regression for the five different positions across all subjects. 
40 
Table 6 Average absolute PEP estimation errors (ms) for each position 41 
Table 7 RMSE (ms) for PEP estimates from SCG signals measured from 
sensors placed in different locations (Str, PMI, LC, RC) 
62 




LIST OF FIGURES 
Figure 1 (a) A healthy person's heart. (b) The heart of an HF patient. It can 
be observed that the heart makes up for the its inability to pump 
enough blood by enlarging, which causes the body to retain 
fluids. Adapted from [3]. 
1 
Figure 2 Changes in heart rate, right ventricular systolic pressure and 
pulmonary artery diastolic pressure before and after 
hospitalization. Adapted from [14]. 
3 
Figure 3 The cardiac cycle and systolic time intervals. 4 
Figure 4 (a) Echo measuring system. (b) The placement of the eight 
electrodes needed to measure the ICG signals. 
6 
Figure 5 (a) Adapted from [44]. A bed equipped with BCG measuring 
sensors. (b) A weighing scale with BCG measuring circuit. (c) A 
force plate used for measuring BCG. (d) Adapted from [45]. A tri-
axial SCG measurement system. (e) An ultra-low noise tri-axial 
instrumentation accelerometer for SCG measurement. (f) Adapted 
from [46]. A wearable patch that measures ECG and SCG signals. 
7 
Figure 6 Sensing ecosystem for heart failure monitoring 8 
Figure 7  A block diagram of the experimental setup. 14 
Figure 8 A 5-seconds time trace showing ECG, ICG, head-to-foot force 
plate BCG. 
15 
Figure 9 Ensemble averaged traces of ECG, ICG, scale BCG, and head-to-
foot force plate BCG with the characteristic points and features. 
16 
Figure 10 (a) Linear regression fit for both scale and force plate head-to-foot 
BCG RI-interval vs PEP among all subjects. (b) Bland Altman plot 
for scale and force plate linear prediction models of PEP. The blue 
line is the 95% confidence range of the PEP estimations from the 
scale BCG RI interval while the red line is the 95% confidence 
range of the PEP estimations from the force plate BCG RI interval. 
20 
Figure 11 (a) Linear regression fit for head-to-foot force plate BCG vs PEP 
during recovery among all 17 subjects. 
21 
Figure 12 Estimated stroke volume percent changes from head-to-foot force 
plate BCG compared to calculated stroke volume percent changes 
from reference ICG. 
23 
 xiii 
Figure 13 (a) a subject standing on the force plate based system for BCG 
signal measurement with feet d cm apart. (b) Average SNR across 
subjects for different stance widths. The lowest SNR was found 
with the feet placed together (0 cm), and the highest SNR was for 
a fairly wide stance (22.9 cm). 
27 
Figure 14 a) Adapted from [58]. An illustration of the experimental setup. (b) 
A 450 ms portion of one ensemble averaged beat of an SCG signal 
collected from the accelerometer placed on the mid-sternal position 
vs SCG signals collected from the other accelerometers at rest. It 
can be observed that the waveforms are very different in their 
shapes and result in different estimations of the aortic valve 
opening (AO) and aortic valve closure (AC) points. 
32 
Figure 15  (a) The variation in AO and peak-to-peak amplitude of the DV 
SCG signal collected from mid-sternum as the physiological state 
of the subject changes between rest and exercise recovery. It can 
be noted that right after exercise the AO time decreases while the 
peak-to-peak amplitude increases only to stabilize back to baseline 
value as time passes. The five rectangles represent the AO and 
peak-to-peak values of the five waveforms shown in part (d) for 
the different physiological states. (b) A 450 ms portion of an 
ensemble average of DV SCG beats collected from the sternum 
during rest and different states during exercise recovery. We can 
observe that the waveforms look similar for a time shift and an 
increase in amplitude after exercise. 
33 
Figure 16 An illustration of some of the top features in the time and frequency 
domain. 
37 
Figure 17 The training and testing sets for training and testing the classifier 
on one of the subjects. The shaded areas are features that are 
excluded from the training set and included in the testing sets when 
trying to detect the sensor position for the subject. 
38 
Figure 18 (a) The best feature in terms of info gain (Peak-to-Peak in the 1st 
250 ms) plotted against the 3rd feature (RMS) for above sternum 
SCG compared to mid-sternum SCG in one of the test sets (b) The 
2nd feature (Standard deviation) plotted against the 4th feature (1st 
peak of the PSD) for above sternum SCG compared to mid-sternum 
SCG in one of the test sets. It is clear in both (a) and (b) that those 
features result in two distinct clusters for these two positions which 
indicates that the position of the sensor (accelerometer) can be 
accurately detected. 
43 
Figure 19 ICG and dorsoventral SCG ensemble averaged traces (n = 5 
heartbeats) obtained with the sensor on the sternum for three 
47 
 xiv 
different subjects. The ICG B-points and SCG AO-points are 
marked with red circles, and there is a substantial time difference 
between the two corresponding points for the three subjects: in two 
cases, the ICG B-point occurs first, and in the third case the SCG 
AO-point occurs first. 
Figure 20 taneously. (b) Five beat ensemble averaged traces of ECG, ICG 
and mid-sternum dorsoventral SCG heartbeats. The ECG R-peak 
is used as a reference point for beat segmentation, the B-point of 
the ICG is used to detect aortic valve opening and the R-B interval 
is used as the ground truth PEP. Peak timing locations and width 
are extracted from the SCG signal as shown. (c) After extracting 
the features from the head-to-foot and dorsoventral axes of the 
SCG signals from all locations, a regression model is used to obtain 
PEP estimates from the features obtained from a single location, 
multiple combination of locations, one axis, and both axes. RMSE 
between the ground truth PEP and every estimate is calculated and 
the optimal location / combination of location and axes is 
determined. 
49 
Figure 21  (a) Different methods of interfacing the ADXL354 accelerometer 
with the sternum. (b) SCG signals obtained from each of the 
different interfacing materials. 
56 
Figure 22 (a). RMSE from PEP estimated from features obtained from 
accelerometers placed on the sternum (Str), point of maximal 
impulse (PMI), below the left clavicle (LC), and below the right 
clavicle (RC) for both the dorsoventral axis (z-axis) and head-to-
foot and dorsoventral axes combined (z+x axes). (b) RMSE from 
PEP estimated from features obtained from the best performing 
combination of accelerometer locations. It can be observed that 
adding more sensors does not substantially reduce the error 
obtained using one sensor below the left or right clavicle. 
61 
Figure 23 Ranking of best 15 features obtained from the combination of 
sensors and axis that rendered the lowest RMSE (Str+LC axis z). 
62 
Figure 24 RMSE from PEP estimated from accelerometers placed on the 
sternum with different interfacing techniques: directly on the 
sternum (Str), in the middle of a silicone rubber sheet placed along 
on the sternum (fstr) and two accelerometers coupled by a rigid 
plastic mold and placed on the upper sternum (US) and lower 
sternum (LS) 
63 
Figure 25 Comparing RMSE for PEP estimates obtained using ensemble 
regression models vs. linear regression models on features obtained 
65 
 xv 
from SCG signals that performed best with XGBoost (i.e., 
LC+sternum z-axis). 
Figure 26 (a) RMSE for PEP estimates obtained using XGBoost on features 
obtained from LC+sternum z-axis while varying the learning rate 
parameter (b) RMSE for PEP estimates obtained using XGBoost 
on features obtained from LC+sternum z-axis while varying the 
column sample parameter. 
65 
Figure 27 Spearman correlation between the top 3 features from signals from 
every location and the I-wave, J-peak, and K-point of scale BCG. 
There was almost no correlation between sternum and PMI features 
with BCG features while good correlation was obtained between 
RC and LC features with BCG features and specifically the I-wave 
and J-peak. (highlighted with the red boxes). 
67 




Heart failure (HF) is a cardiovascular disease characterized by a weakened 
myocardium, where the heart is unable to supply sufficient blood to the tissues and organs. 
It affects nearly 6 million Americans with annual health care costs in the United States 
being almost $31 billion, half of which are due to hospitalizations. Therefore, there has 
been great interest in developing novel methods for monitoring patients with HF at home 
to potentially reduce hospitalizations. This monitoring can be achieved by sensing the 
mechanical aspects of the cardiovascular health, specifically the estimation of systolic time 
intervals, such as the pre-ejection period (PEP), outside of clinical settings. PEP is a 
surrogate measure of myocardial contractility; an increased PEP signifies decreased 
contractility and hence, a weakened myocardium.  
Unfortunately, existing technologies for non-invasive PEP measurements are 
expensive, obtrusive, and usually require a trained medical professional. Recent research 
has shown that ballistocardiogram signals (BCG), which measure the reactionary forces of 
the body in response to cardiac ejection of blood in the vasculature, and seismocardiogram 
signals (SCG), which measure local chest vibrations associated with the heart and blood 
movement, can be used to estimate systolic time intervals, including PEP. BCG and SCG 
can be measured using unobtrusive and inexpensive equipment, such as weighing scales 
with added circuitry and low noise accelerometers. However, there are gaps in the research 
that must be bridged before BCG and SCG can be reliably used in unsupervised settings to 
monitor cardiovascular health. 
 xvii 
This work focuses on bridging some of these existing gaps. New hardware to 
measure BCG was explored by using a high bandwidth force plate and further signal 
processing techniques which allowed for significant improvement in absolute 
measurements of PEP, and measurements of changes in stroke volume, over current state-
of-the-art technology. Additionally, since SCG signals measure local vibrations, the 
relationship between sensor placement and the morphology of the signals was investigated. 
This was done by designing a robust algorithm that distinguishes between changes in 
morphology resulting from placement and changes resulting from physical activities, and 
consequently, detects misplacement of the SCG sensors allowing for robust PEP 
monitoring in unsupervised settings. Moreover, different placements and interfaces of SCG 
sensors, on the upper body, were explored to identify the ideal position/ combination of 
positions. This showed, for the first time, that better PEP estimates can be obtained by 
placements different than what is currently used in research. Finally, a universal ensemble 
regression model, that uses multiple features to estimate PEP from SCG signals, is 
presented in this work. This algorithm bypasses the lack of a well-defined standard to detect 
the aortic valve (AO) opening from SCG, resulting from the signals morphology being 
affected by age, sex and heart condition. 
The algorithms and methods presented in this work, pave the way towards enabling 
accurate and robust monitoring of the mechanical health of the cardiovascular system. 
Using these unobtrusive, inexpensive systems for HF patients would increase their quality 
of life by reducing rehospitalization, and therefore reducing the associated healthcare costs. 
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CHAPTER 1. INTRODUCTION 
1.1 Motivation 
Cardiovascular diseases (CVD) are the leading cause of death in the United States, 
according to the American Heart Association. A particularly prevalent CVD is Heart 
Failure (HF), which is caused by weakened myocardial contractility which leads to the 
inability of the heart to supply the cells with the amount of blood needed for normal 
function [1]. This results in shortness of breath, fatigue and swelling in the ankles, feet, 
legs, abdomen, and veins in the neck. Those symptoms result from the fluid build-up in the 
body due to the enlargement of the heart chambers as the ventricular muscles become 
weaker [2]. Figure 1(a) shows a healthy heart while Figure 1(b) shows the heart of an HF 
patient. 
 
Figure 1. (a) A healthy person's heart. (b) The heart of an HF patient. It can be observed 
that the heart makes up for the its inability to pump enough blood by enlarging, which 
causes the body to retain fluids. Adapted from [3]. 
Today, 5.7 million Americans are living with HF and 1 in 9 deaths results directly 
from it [4, 5]. It costs the nation a total of $30.7 billion in medical costs. Projections show 
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that the number of Americans diagnosed with HF will rise to 8 million by 2030, a 46% 
increase from today’s estimates [6]. Moreover, it is estimated that the medical cost of HF 
will increase by 127% to a total of $69.7 billion [6]. Another staggering statistic shows that 
approximately 27% of patients with HF are readmitted to the hospital within 30 days of 
their discharge with this number increasing to more than 50% readmission rate within 6 
months [7, 8]. Intuitively, reducing rehospitalization rates would provide HF patients with 
a better quality of life and would reduce the medical cost associated with the disease.  
There has been a significant increase in the efforts aiming to reduce hospital 
readmission rates and make care proactive through continuous home monitoring of HF 
patients [9]. It was thought that monitoring the weight of HF patients can help in detecting 
worsening conditions and adjusting the medication accordingly since decompensation 
leads to fluid build-up in the body which would lead to an increase in weight [10]. 
However, a study based on a large population of HF patients showed that telemonitoring 
patients based on their weight fails to provide additional benefit over usual care and does 
not lead to a decreased readmission rate [11]. This can be attributed to the fact that a 
patient’s weight can increase due to higher caloric intake rather than from gaining fluid 
weight, which can lead to false positives. Similarly, the patient may be gaining fluid weight 
but at the same time losing body fat or skeletal muscles which would prevent the increase 
of the overall body weight [12, 13].  
Later research showed that most HF readmissions are a result of an increase of the 
ventricular filling pressure which can be observed up to 6 days prior to symptoms onset as 
shown in Figure 2 [14].  However, studies have shown that the only efficient way in 
monitoring that in a home setting is through the use of implantable hemodynamic 
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monitoring (IHM) devices [15]. These devices have a very high cost with CardioMEMS 
IHM costing around $25,000.  
 
Figure 2. Changes in heart rate, right ventricular systolic pressure and pulmonary artery 
diastolic pressure before and after hospitalization. Adapted from [14]. 
However, there are physiological features other than ventricular filling pressure that 
can potentially allow the prediction of exacerbations in HF patients; those are the systolic 
time intervals. Each cardiac cycle is divided into filling and ejection periods, also known 
as diastole and systole. The time spent by the heart in each of these periods is an important 
marker of the mechanical function of the heart and vasculature, and thus provides insight 
into the health of the cardiovascular system. Therefore, accurate measurement of the 
timings of these periods, and in particular systole, is important in monitoring patients with 
cardiovascular diseases, including HF patients. Systole is divided into two time intervals 
known as the systolic time intervals (STI): pre-ejection period (PEP), which is the period 
of isovolumetric contraction, and left ventricular ejection time (LVET), which is the period 
of systolic ejection [16].  The cardiac cycle and the systolic time intervals are shown in 




Figure 3. The cardiac cycle and systolic time intervals. After [17].  
PEP is the time elapsed between the electrical depolarization of the ventricular 
muscle and the ensuing opening of the aortic valve [18], and is a surrogate measure of 
myocardial contractility [19]. Specifically, increased PEP signifies decreased contractility, 
and vice versa, since a weakened myocardium will have lowered maximal rate of left 
ventricular pressure increase (dP/dtmax) during isovolumetric systole. Therefore, an 
increased PEP can potentially be a sign of decompensation in HF patients.  Hence, to 
realize out-of-clinic monitoring of HF patients and transition from reactive to proactive 
care, it is important to accurately measure STIs non-invasively, unobtrusively, and without 
the need for a health care professional. 
Current non-invasive wearable technologies for cardiovascular monitoring are 
limited to cardiac electrophysiology measurements through electrocardiogram (ECG) [20, 

































Although these technologies are noninvasive (wristband, smartwatches, adhesive patches, 
etc..[24]) and inexpensive, they can only provide information related to heart rate and 
rhythm but no information related to the mechanical aspects of the cardiovascular function 
and STIs such as PEP [25]. 
Existing technologies for noninvasive PEP measurement are obtrusive, and 
impractical for large scale use in HF monitoring. The reference standard for noninvasive 
PEP measurement is echocardiography, which uses ultrasound. An ultrasound transducer 
is placed over the chest and the sound waves bounce off the heart and echo back to the 
transducer. The waves are then changed into pictures viewed on a video monitor. The 
apparatus used for that is large and expensive and has be operated by trained medical staff 
[26, 27]. Impedance cardiography (ICG) was validated against echo as a reliable way of 
measuring PEP [28], however, it is also difficult to use in out-of-clinic settings. ICG is 
obtrusive to measure as it requires a trained medical professional to apply eight electrodes 
to the subject and operate the measuring device [29, 30]. Moreover, although some studies 
have shown that serial ICG measurements can predict the risk of acute decompensation 
[31], the requirement of frequent office visits and sensitivity to electrode positioning make 
this technology inapplicable on a larger scale [32]. Recently, researchers have developed a 
wearable system to measure ICG through textile integration [26], however, a more 
convenient way that would allow users to wear their standard clothing and still be able to 
obtain continuous PEP measurements is still needed. Conventional Echo and ICG 




Figure 4. (a) Echo measuring system. (b) The placement of the eight electrodes needed to 
measure the ICG signals. 
Recent studies have shown that the ballistocardiogram (BCG) signal, a measurement 
of the recoil forces of the body in response to the ejection of blood from the heart and 
movement of the blood through the vasculature [33, 34], and seismocardiogram (SCG) 
signals, representing the local chest vibrations associated with heart and blood movement, 
can be used to estimate systolic time intervals including PEP [33, 35].  
BCG was first discovered by J. W. Gordon in 1877 when he observed that the needle 
of a scale, on which a person was standing, was synchronously vibrating with each 
heartbeat. He attributed that movement to the upward recoil force of the body as the blood 
is ejected downward into the aorta which he compared to the recoil force resulting from 
the propelling of a bullet from a gun [36]. However, it was not until 1939 that this signal 
was measured by Starr using a table-like instrument and he suggested that it can be used to 
estimate changes in cardiac output [34]. Despite that, BCG research did not gain 
momentum until the 21st century as developing small and low-cost sensors to measure it 
was not feasible before then. BCG can be measured using instrumented beds [37] and 
(a) (b)
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chairs [38], weighing scales [39] and force plates [40]. Figure 5 (a), (b), and (c) shows 
some of the BCG acquisition hardware. 
Likewise, and in contrast to the ICG, SCG measurements do not require any medical 
professional to administer the test, and in terms of hardware can be rather compact and 
unobtrusive as it is usually measured using a high resolution miniature accelerometer [41-
43]. Acceleration can be measured in the 3-dimensions (head-to-foot, dorsoventral, and 
lateral), but most studies focus on the dorsoventral component. Since SCG measure local 
vibrations, the signal is impacted by the exact location of the sensor on the chest. Figure 5 
(d), (e), and (f) shows some of SCG acquisition hardware. 
 
Figure 5. (a) Adapted from [44]. A bed equipped with BCG measuring sensors. (b) A 
weighing scale with BCG measuring circuit. (c) A force plate used for measuring BCG. (d) 
Adapted from [45]. A tri-axial SCG measurement system. (e) An ultra-low noise tri-axial 
instrumentation accelerometer for SCG measurement. (f) Adapted from [46]. A wearable 
patch that measures ECG and SCG signals. 
The aim of this research is to pave the way for continuous out of clinic monitoring 
of patients with HF using systolic time intervals estimations obtained from SCG and BCG. 
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The end goal would be for the patient to take an SCG wearable device, or a BCG scale 
home, use the device on a daily basis while measurements are recorded and pushed into a 
cloud. STI estimation algorithms are then run on the data and the outputs are accessed by 
physicians, who will notify the patient if an adjustment of treatment is needed, allowing 
for titration of care. Figure 6 shows the vision for a sensing ecosystem for heart failure 
monitoring. 
 
Figure 6. Sensing ecosystem for heart failure monitoring 
1.2 Major Contributions of this Work 
There has been a considerable amount of work done on the use of BCG and SCG 
for measuring mechanical parameters of the cardiovascular function. However, there are 
gaps in the research that must be bridged before BCG and SCG signals can be reliably used 
in unsupervised settings to monitor the cardiovascular health. 
∆








To measure BCG signals, a weighing scale with a strain gauge bridge and analog 
amplifier circuit is used. Weighing scales are usually designed to measure DC body 
weights, and using them to measure BCG signals, which are AC changes, could impose 
limitations. Additionally, the uneven group delay in the passband can potentially distort 
the BCG waveform and reduce the accuracy of STI measurements.  
SCG signals result from local chest vibrations, therefore, the placement of the sensor 
affects the shape of the measured signals. This change in morphology, if not detected, 
affects the accuracy of the STI measurements. Hence, it is important to study SCG sensor 
placement, whether that is to identify the ideal positioning, or to control for misplacements. 
Additionally, the morphology of the SCG signal and its fiduciary points changes 
significantly with gender, age, and cardiac conditions, making it difficult to develop a 
standard method to detect these fiduciary points needed for PEP estimation, limiting SCG 
to subject-specific calibration and monitoring.   
With these limitations in mind, the main contributions of this work are given below: 
1. Demonstrated significant improvement in STI estimation accuracy compared to 
state-of-the-art BCG instrumentation using a high bandwidth force plate, 
showing that it is possible to use BCG signals to measure absolute values of PEP 
rather than only relative changes. 
2. Demonstrated for the first time that placement based changes in SCG 
morphology can be differentiated from physiological changes and devised an 
algorithm to automatically detect sensor misplacement in unsupervised settings, 
improving PEP measurement accuracy by more than 10 ms. 
 10 
3. Identified the optimal placement and interfacing method for SCG sensors on the 
upper body. This resulted in showing, for the first time, that improved PEP 
estimates (~30% improvement) can be obtained by placements different than 
what is currently used in research.  
4. Devised a universal ensemble regression model, that uses multiple features 
extracted from the SCG signals, to estimate PEP. This model bypasses the lack 
of a well-defined standard to detect the aortic valve (AO) opening from SCG, 
and is robust to slight changes in placement since it is global, rather than subject-
specific. 
1.3 Thesis Organization 
The rest of this thesis is organized as follows: Chapter 2 focuses on BCG signals as 
the modality for non-invasive monitoring of the mechanical health of the cardiovascular 
system while both chapter 3 and chapter 4 focus on SCG wearable sensors for enabling 
continuous monitoring in the context of normal stressors encountered by the person during 
their everyday activities. 
Chapter 2 investigates acquiring BCG signals with a high bandwidth force plate 
compared to the modified weighing scale in terms of STI estimation accuracy. The 
increased bandwidth is then leveraged to estimate per-subject stroke volume changes. In 
Chapter 3, we explore the effect of sensor placement on the shape of SCG signals, prove 
that inaccurate placement can lead to inaccurate estimates of STIs, and present an algorithm 
that detects sensor misplacement in an unsupervised setting. Further placements are 
examined in chapter 5 and sensor fusion techniques, at the feature level, are used to identify 
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the ideal combination of sensor locations. Additionally, a non-linear universal model, to 
estimate PEP from multiple features in the SCG signal, is developed using ensemble 
regression techniques. Finally, Chapter 5 concludes the work in this thesis and provides 





CHAPTER 2. UNOBTRUSIVE ESTIMATION OF CARDIAC 
CONTRACTILITY AND STROKE VOLUME CHANGES USING 
BALLISTOCARDIOGRAPHY MEASUREMENTS ON A HIGH 
BANDWIDTH FORCE PLATE 
2.1 Introduction 
The modified weighing scale used to measure BCG in [47] can be modeled as a 
second-order mechanical system. The spring constant and associated mechanical 
bandwidth for a range of bodyweights for typical adults were characterized (>15 Hz 
bandwidth for bodyweights of 150 kg or less) [47]. This mechanical bandwidth, while 
sufficient for not attenuating any of the frequency components of interest for BCG 
recordings, may potentially distort the BCG waveform and reduce the accuracy of timing 
interval measurements due to uneven group delay in the pass-band. 
Therefore, we compare the modified weighing scale to a high bandwidth, reference 
standard force plate to evaluate the accuracy in PEP estimation. We also estimate per 
subject ∆SV (i.e., relative changes in stroke volume) using the force plate BCG and verify 
the accuracy against simultaneously measured reference standard ICG measurements. 
2.2 Methods 
2.2.1 Protocol 
 The study was conducted under a protocol reviewed and approved by the Georgia 
Institute of Technology Institutional Review Board (IRB). All subjects provided written 
consent before experimentation. Data were collected from 17 healthy subjects (Gender: 10 
males, 7 females; Age: 23.6 ± 4.5 years, Height: 172.8± 9.9 cm, Weight: 70.7±11.3 kg). 
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Each subject was asked to stand still in an upright position for 60 seconds on each of the 
force plate and scale for baseline measurements. After that, each subject performed a 
stepping exercise for 60 seconds after which they were asked to stand on the force plate as 
still as possible for 5 minutes to monitor their full recovery. Half of the subjects stood on 
the scale first during baseline measurement while the other half stood on the force plate 
first to account for any bias due to the order in which the subject stood on the force plate 
versus the scale. In addition to the BCG, we measured the ECG and ICG. The ECG was 
used as timing reference to ensemble average the BCG and ICG signals. The B-point of 
the ICG was used as a reference method for detection of the opening of the aortic valve 
[16, 48]; it was also used for reference ∆SV calculations. 
2.2.2 Hardware Design 
 Two different instruments were used to measure the BCG: a modified electronic 
weighing scale and a high bandwidth multi-component force plate. The modified weighing 
scale (BC534, Tanita, Tokyo, Japan) was developed in previous work using an analog 
amplifier and a strain gauge bridge [47]. The multi-component force plate (Type 9260AA6, 
Kistler Instrument Corp, NY, USA) has a bandwidth in excess of 200 Hz and sufficient 
resolution to enable BCG measurements in all three axes. The force plate has four, three-
component force sensors. Each of the four sensors has three pairs of quartz plates, one 
sensitive to pressure in the z-direction (head-to-foot) and two to shear in the x and y-
directions (dorsoventral and lateral respectively). Out of the 12 output signals, two of the 
shear forces that have the same line of action can be paralleled, so the outputs of the force 
plate are eight signals instead of 12. Since we only process head-to-foot BCG in this work, 
we accessed each of the four signals in the z-direction separately, passed each one of them 
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as an input to an amplifier and filter circuit, and then the outputs of these four components 
were added using an adder circuit. The summed, amplified and filtered head-to-foot BCG 
signal was outputted into the data acquisition system (MP150, BIOPAC System Inc., 
Goleta, CA). The ECG and ICG signals were measured using BN-RSPEC and BN-NICO 
wireless modules respectively (BIOPAC Systems, Inc., Goleta, CA) then transmitted to the 
MP150. All signals were sampled at 2 kHz.  Figure 7 shows a block diagram of the 
experimental setup and Figure 8 shows a time trace of ECG, ICG, and head-to foot BCG. 
 
Figure 7. A block diagram of the experimental setup.  
2.2.3 Data Processing 
 The BCG, ICG, and ECG signals were filtered with finite impulse response (FIR) 
Kaiser window band-pass filters with cut-off frequencies as follows: 0.8-35 for ICG and 
ECG, 0.5-20 for head-to-foot BCG. The ECG R-peaks were detected using an automated 
peak detection algorithm and verified manually. This was done by computing a constant 




















ECG signal for each subject; local maxima, greater in amplitude than this threshold, were 
then located automatically and annotated as R-waves. The minimum R-R interval was 
calculated for every subject and the detected R-peaks were used as a fiduciary to segment 
ICG and BCG signals into individual heart beats, each with a window length equal to the 
minimum R-R interval. These extracted heartbeats were then averaged to obtain ensemble 
averaged traces with reduced noise. 
 
Figure 8. A 5-seconds time trace showing ECG, ICG, head-to-foot force plate BCG. 
2.2.4 Feature Extraction  
 The I-wave in the weighing scale and force plate BCG signals was obtained by 
detecting the minima before the global maxima in the first 200 ms portion of the 
corresponding BCG ensemble average. The J-peak and its amplitude (from the reference 
threshold, i.e. 0) were detected as the global maxima of the force plate and scale BCG 
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derivative of the ICG [30].  The X-point was obtained by detecting the minima after the 
global maxima of the ICG. The amplitude of the maxima of the ICG was also detected. 
Figure 9 shows ensemble averages of ECG, ICG, scale BCG and head-to-foot force plate 
BCG signals with the extracted features.  
 
Figure 9. Ensemble averaged traces of ECG, ICG, scale BCG, and head-to-foot force plate 
BCG with the characteristic points and features. 
2.2.5 Correlation at Rest 
 The 60 seconds baseline recording of scale BCG, force plate head-to-foot BCG, 
and ICG were divided into 12 5-second windows and an ensemble average was obtained 
for each of the 12 windows. For each of those ensemble averages, the RI duration was 
calculated (the timing at which the I-wave occurs since the ensemble averaging is done 
with respect to the ECG R-peak) and PEP was calculated (the timing at which the B-point 
– opening of the aortic valve – occurs). Although PEP is defined as the time elapsed 
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ECG is not always as robust as detecting the R-point. Hence, in our analysis we used the 
R-peak in ECG as a reference and estimated PEP as the RB interval since we are most 
interested in relative changes in PEP rather than absolute measures, and the QR interval is 
typically consistent from beat-to-beat A correlation analysis was then performed between 
RI-intervals in both scale and force plate and the corresponding PEP values (from ICG) 
among all 17 subjects. 
2.2.6 Correlation during Exercise Recovery 
 The 5 minutes after exercise recovery recording of head-to-foot force plate BCG 
and ICG were divided into 15 20-second windows. As compared to the rest data, a longer 
time was required for extracting the ensemble averages (20 seconds compared to 5 seconds) 
due to increased postural sway in exercise recovery compared to rest. An ensemble 
average, RI interval and PEP were calculated for each of the 15 windows. A correlation 
analysis was then performed between RI intervals and PEP among all 17 subjects. 
2.2.7 Estimating Relative Changes in Stroke Volume 
 Stroke volume SV1 was calculated for each subject during rest using the reference 




















1  (1) 
where H is the height of the subject, Z0 is the base impedance of the thorax, dz/dtmax is the 
amplitude of the global maxima of the ICG (defined as the first derivative of the thoracic 
impedance as a function of time), and LVET is the left ventricular ejection time which is 
calculated as the timing difference between X-point and B-point in the ICG. 
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 Then, for each of the 17 subjects separately, the 5 minutes after exercise recovery 
recording of head-to-foot force plate BCG and ICG were divided into 15 20-second 
ensemble averages (as with the PEP estimation described above). The normalized change 











 For each subject, subject specific correlations were performed between the J-peak 
of the force plate BCG and the X-point of the ICG and between the I-wave of the force 
plate BCG and the B-point of the ICG. Linear regression models were found for each 
subject and used to estimate the X-point, X̂ ,  and B-point, B̂ , in every ensemble average. 
Estimated LVET for each of the 15 ensemble averages for each subject was then calculated. 
 Similarly, another subject-specific correlation was performed between the 
amplitude of the J-peak and dz/dtmax, and the linear regression model was used to estimate 
dz/dtmax for the ensemble averages for that subject. Finally, the estimated ∆SV was 
calculated for each of the 15 ensemble averages for every subject and the resulting 
estimates were compared with the reference ∆SV calculated from ICG. 
2.2.8 Signal-to-Noise Ratio Calculations 
 For each of the 17 subjects, an ensemble average x was obtained for the 60 second 
baseline recording of weighing scale BCG and head-to-foot force plate BCG. The 60 
second window was then divided into 12 5-second sub-ensembles xi and a sub-ensemble 
average ix  was obtained for each of the 12 sub-ensembles. 5-second ensembles were used 
rather than individual beats to reduce motion artifacts. Noise was calculated for each of the 
sub-ensemble averages using: 
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 xaxn iii   (3) 
where 𝑎𝑖 is the normalization coefficient for the amplitude of the ensemble averaged BCG 
































2.3 Results and Discussions 
2.3.1 RI and PEP Correlation for Scale and Force Plate BCG during Rest 
 The correlation results were: 85.02 r , 97.0m , 92.34b  for the force plate 
and 81.02 r , 92.0m , 23.24b  for the scale, with m being the slope and b being the 
y-intercept. These results show an improved timing accuracy in force plate compared to 
scale BCG in estimating PEP, demonstrating that the limited mechanical bandwidth in the 
weighing scale impacts the timing accuracy. Figure 10(a) shows a linear regression fit for 
scale and force plate BCG RI-intervals vs PEP and Figure 10(b) is a Bland Altman plot 
[50] that shows a larger standard deviation in PEP estimated from scale BCG compared to 
PEP estimated from force plate BCG.  
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2.3.2  RI and PEP Correlation for Head-to-Foot Force Plate BCG during Recovery 
 The results were: 92.02 r , 14.1m , 46.14b . Figure 11(a) shows a linear 
regression fit for force plate head-to-foot BCG vs PEP during recovery. The higher 
correlation of head-to-foot BCG I-wave to PEP during exercise recovery compared to that 
during rest ( 85.02 r ) can be attributed to the more significant changes in PEP and RI 
intervals during exercise recovery as both values increase to stabilize again at the baseline 
values. Additionally, higher frequency information in after exercise BCG, as can be 
observed in Figure 11(b), is another cause of increased accuracy over rest BCG. These 
results show a better correlation coefficient (0.92 versus 0.86) and a much smaller y-
intercept (14.6 versus 138) than the results obtained from correlating RJ interval to PEP in 
the previous work [47]. One of the future work objectives in that paper was to examine 
waves other than the J-wave for better correlation and smaller y-intercept but that was not 
















































Figure 10. (a) Linear regression fit for both scale and force plate head-to-foot BCG RI-
interval vs PEP among all subjects. (b) Bland Altman plot for scale and force plate linear 
prediction models of PEP. The blue line is the 95% confidence range of the PEP estimations 
from the scale BCG RI interval while the red line is the 95% confidence range of the PEP 
estimations from the force plate BCG RI interval. 
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feasible because of the difficulty of detecting those other waves during exercise recovery. 
However, with the force plate BCG, we were able to successfully extract the I-waves from 
all subjects and hence obtain the improved results.    
 
Figure 11. (a) Linear regression fit for head-to-foot force plate BCG vs PEP during 
recovery among all 17 subjects. (b) Power spectral density of the force plate BCG 
waveforms that correspond to the SV estimates marked in (a). Higher frequency 
information exists in after exercise BCG (waveform 1) compared to rest BCG (waveform 
2).   
2.3.3  Stroke Volume Estimation from Head-to-Foot Force Plate BCG during Recovery 
The mean error among all subject was 5.3% with a standard deviation of 4.2%. We 
compared our results to other studies providing such detailed error analysis information on 
non-invasive SV estimation. In the ones available [51-54], the following results were 
achieved and considered “acceptable”. In [51], the mean error was 16.5% for SV derived 
from femoral arterial blood pressure (ABP) and 14.5% for SV derived from radial ABP. In 
[53], the mean error was 8.9% for SV estimated using mean arterial pressure (MAP) and 
14.35% for SV estimated using the systolic waveform. In [54], the percentage error 
































cardiac output (CO) –which is obtained from multiplying SV by heart rate – was 29%. All 
of these results were considered acceptable. In [52], the comparison between SV estimation 
using the Vigileo-FloTracTM system and esophageal Doppler yielded an error rate of 58% 
which was deemed unacceptable, since according to [55], limits of agreement of ±30% are 
acceptable. Hence, our method allows ∆SV estimations for every subject accurately and 
can provide insight in the case of HF patients.  
Additional comparison with the cardiac output estimation methods that were 
summarized in [39] is shown in Table 1. It should be noted here that these works used 
different gold standards to compare their methods against. All non-invasive gold standards, 
including ICG, are susceptible to errors compared to invasive measurements such as 
thermodilution or Fick’s method. However, we did not have access to the invasive 
measurements methods and ICG, which is often used in research, has proved good 
correlation with Fick’s method. Therefore, when interpreting the results, we should take 
into consideration inherent errors in the gold standard. The per-subject results of the 
absolute and percentage mean and standard deviations of the estimated ∆SV compared to 
the reference calculations are shown in Table 2.  Figure 12 also shows the percentage ∆SV 
in comparison with the calculated percentage ∆SV from ICG. 
We can observe in Figure 12 that the change in SV is positive in some cases while 
negative in other cases. This can be attributed to the fact that SV increases during exercise 
and then decreases again during exercise recovery and it sometimes goes below the 
baseline SV by the end of the recovery period. Hence, at the beginning of the recovery 
period, the change in SV would be positive while at the end of the recovery period the 
change in SV would be around zero or sometimes negative.  
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Table 1. Comparison of several studies on non-invasive cardiac output measurement for 
exercise and exercise recovery (healthy subjects).  
 
Figure 12. Estimated stroke volume percent changes from head-to-foot force plate BCG 





























This work Ballistocardiography ICG 17 255 0.96 
Inan et al (2009) Ballistocardiography Doppler echo 9 275 0.85 
Houtman et al (1999) Cont. Blood Pressure Gas rebreathing 12 24 0.46 
Sugawra et al (2003) Cont. Blood Pressure Doppler echo 16 640 0.76 
Antonutto et al (1995) Cont. Blood Pressure Doppler echo 9 27 0.77 
Christie et al (1987) Doppler echo Fick (direct) 10 42 0.66 
Wilmore et al (1982) Gas rebreathing Thermodilution 6 12 0.76 
Liu et al (1997) Gas rebreathing Fick (direct) 9 37 0.77 
Johnson et al (2000) Gas rebreathing Fick (direct) 6 96 0.90 
Zhang et al (1986) ICG Gas rebreathing 10 78 0.91 
Miyamoto et al (1981) ICG Gas rebreathing 6 19 0.83 
Moore et al (1992) ICG Gas rebreathing 11 44 0.76 
Hatcher and srb (1986) ICG Gas rebreathing 60 230 0.56 
Trodie et al (2004) ICG Gas rebreathing 8 40 0.82 
Richard et al (2001) ICG Fick (direct) 12 50 0.88 
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Table 2. Per subject errors in ∆SV estimation. 
Subject μ Error (ml) σ Error (ml) % μ Error % σ Error 
1 2.0 1.7 3.6 3.1 
2 1.4 0.9 3.4 2.3 
3 3.7 2.6 6.5 4.6 
4 4.0 4.9 5.4 6.7 
5 2.5 1.8 6.4 4.7 
6 2.8 2.0 8.9 6.4 
7 3.4 3.1 6.6 6.0 
8 2.8 2.6 4.6 4.3 
9 5.6 4.9 11.0 9.5 
10 3.4 2.5 4.5 3.4 
11 3.1 3.0 5.3 5.1 
12 3.3 1.4 5.2 2.1 
13 1.6 1.3 3.3 2.8 
14 1.9 1.4 4.6 3.3 
15 1.0 0.8 2.2 1.8 
16 3.4 1.8 4.7 2.5 
17 3.5 2.5 4.6 3.2 
Average 2.9 2.3 5.3 4.2 
 
2.3.4 Signal-to-Noise Ratio Comparison for Scale BCG and Force Plate Head-to-Foot 
BCG 
SNR results show slightly better SNR values for force plate head-to-foot BCG 
compared to scale BCG. The results for SNR calculations are shown in Table 3.  
Table 3. Per subject SNR calculations for scale and force plate BCG. 
subject Gender Height (cm) Weight (kg) FP SNR (dB) Scale SNR (dB) 
1 Female 160 59 6.0 5.6 
2 Male 175 75 8.6 7.6 
3 Female 168 68 8.1 5.3 
4 Female 160 52 1.7 1.3 
5 Male 183 86 8.3 4.3 
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6 Male 175 74 1.5 -1.8 
7 Female 152 49 5.5 4.6 
8 Male 178 65 3.4 1.7 
9 Male 178 88 1.6 1.5 
10 Male 178 68 2.6 1.2 
11 Male 190 88 7.1 5.1 
12 Female 175 68 9.0 8.1 
13 Male 175 70 3.8 3.8 
14 Male 185 76 8.3 8.3 
15 Male 175 79 3.1 2.7 
16 Female 163 75 6.7 6.6 
17 Female 168 61 8.0 7.8 
The force of the BCG signal is 2 Npp and the sensitivity of the transducer in the 
weighing scale is 19.1 μV/N [16] which would give a BCG voltage of 38.2 μVpp. The 
noise level referred to the input of the circuit is 150 nVpp. This would lead to an SNR of 
255 in the linear scale or 48 dB. As for the force plate, with the same BCG amplitude of 2 
Npp for the BCG and a sensitivity of 19 mV/N amplified by 250 times in the z-direction 
gives a signal of 9.5 Vpp. The output noise level is 5mVpp which leads to an SNR of 1900 
in the linear scale or 66 dB. Those calculations are clearly far better from what we are 
obtaining in terms of SNR for both the scale and force plate so the difference cannot be 
attributed to this. Hence, it is likely that the BCG SNR is limited by motion artifacts, not 
electronic noise.  
Moreover, we observed the order in which subjects stood on the scale and force 
plate (since half the subjects stood on scale first while the other half stood on the force 
plate first) to account for any bias due to the order in which the subject stood on the force 
plate versus the weighing scale, and found that the difference in SNRs between force plate 
and weighing scale BCG was bigger for all the subjects that stood on the force plate first 
(subjects: 2,3,5,6,8,10,11, and 12 in Table 3) compared to those who stood on the weighing 
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scale first (subjects: 1,4,7,9,13,14,15,16, and 17 in Table 3). For both groups, the results 
are statistically significant (P<0.05).  
We hypothesized that the improvement in SNR in force plate BCG over scale BCG 
is a result of the subject being able to stand more comfortably on the force plate with their 
feet wider apart than with the scale. To further investigate this theory, we had 7 healthy 
subjects (5 males, 2 females; ages: 24.9±1.6 years; height: 174.6±12.7 cm; weight: 
73.2±18.4 kg) stand on the force plate with feet 0, 7.6, 12.7 (same distance as for the scale), 
22.9, 27.9 cm apart for 60 seconds each. In addition to BCG, we measured the ECG. Same 
filtering, R-peak detection, ensemble averaging, and SNR calculation methods were used 
as described earlier in this chapter.  
Results showed that the ideal stance width from highest BCG SNR varied from 
subject to subject. four subjects had the highest SNR BCG with feet 22.9 cm apart, one 
with feet 27.9 cm apart, one with feet 12.7 cm apart, and one with feet 7.6 cm apart. No 
relation was found between the optimal distance and the height or weight of the subjects. 
However, on average, the highest SNR of 7.1 dB was found when the feet were 22.9 cm 
apart (wide) and the lowest SNR of 4.2 dB occurred when feet were together (i.e. 0 cm 
apart). The average results among all subjects are shown in Figure 13. 
While these findings were not consistently better for distances wider than BCG 
scale stance for every subject, an important conclusion from this experiment is that in 
longitudinal studies, where BCG waveforms are compared from one day to the next, it 
would be important to control the distance between the feet. This could be accomplished, 
for example, by providing some reference indicators on the force plate platform for foot 
placement.   
 27 
 
Figure 13. (a) a subject standing on the force plate based system for BCG signal 
measurement with feet d cm apart. (b) Average SNR across subjects for different stance 
widths. The lowest SNR was found with the feet placed together (0 cm), and the highest 
SNR was for a fairly wide stance (22.9 cm).  
2.4 Conclusions 
We have shown that force plate BCG allows for more reliable PEP estimations than 
scale BCG due to more accurate timing information that can be attributed to the wider 
bandwidth of the force plate. We have also shown that force plate head-to-foot BCG can 
be used to estimate ∆SV accurately. However, in order to determine subject-specific 
coefficients for how the BCG parameters relate to the ICG parameters, simultaneous ICG 
measurements are needed at first for calibration purposes. Hence, the estimation of ∆SV 
hinges on having the initial reference measurement. Nevertheless, for the HF patients 
monitoring application, such initial measurements of SV can be obtained at the index visit, 
and then the BCG-equipped force plate can be used to measure changes from that initial 
value over time. Changes in SV could then be used to titrate care, thus potentially leading 
to improved outcomes and reduced costs. 






















Nevertheless, the cost of the force plate is significantly higher than the weighing 
scale, and thus the force plate – at this current cost – would not be feasible for at-home use. 
If the force plate was positioned in a central location accessible to multiple HF patients 
such as in a grocery store, the cost of the force plate could be amortized over the large 
number of patients that could access the device, thus allowing it to be a feasible option for 
monitoring patients outside the clinic / hospital setting. A more feasible method of non-
invasive and unobtrusive monitoring of HF patients would be to obtain SCG signals from 
wearable sensors. This would be more cost-effective and it would provide the health care 
providers with continuous PEP estimates from patients, which could potentially lead to a 
more efficient form of proactive care. 
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CHAPTER 3. CLASSIFICATION OF WEARABLE 
SEISMOCARDIOGRAM SENSOR POSITIONING FOR ROBUST 
ESTIMATION OF THE PRE-EJECTION PERIOD IN 
UNSUPERVISED SETTINGS 
3.1 Introduction 
While the modified weighing scale or force plate can potentially enable 
measurement of STIs outside of the clinical setting, measurements are limited only to when 
the subject stands on the platform. To facilitate more frequent measurements, and 
specifically measurements during periods of great interest clinically such as when a person 
is performing exercise (e.g., walking up a flight of stairs), we also investigated techniques 
for robust measurement of STIs using wearable devices. Importantly, it has been recently 
demonstrated that the PEP measured using ECG and SCG waveforms taken by a small 
wearable patch before and after walking can be used to distinguish between compensated 
and decompensated HF patients, indicating that the measured SCG signal quality is 
sufficiently high for this clinical population for cardiovascular health assessment purposes 
[46].   
However, one key challenge with using SCG signals for PEP estimation is that the 
position of the accelerometer on the chest may affect the relationship between the “AO” 
point detected on the SCG signal and the ground truth aortic valve opening timing detected 
by a reference standard measurement (e.g., an ICG). For mid-sternal SCG measurements, 
the AO point corresponds to the B-point of the ICG closely in time across different subjects 
and thus can directly be used as the endpoint for PEP time interval estimation (with the 
ECG Q-wave being the starting point). However, since SCG is a measure of local 
accelerations of the chest wall, changing the positioning of the sensor can change the shape 
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of the SCG signal [56], and thus the relationship between the AO point detected by the 
SCG and the actual timing of aortic valve opening. Specifically, the regression curve 
linking Q-AO to Q-B intervals across subjects would have different slope and y-intercept 
for each position on the chest for SCG measurements. Thus, if the position of the 
accelerometer on the chest is not known a-priori, the timing intervals extracted from the 
SCG signals may not accurately reflect the underlying physiology of the heart.  
This positioning problem is not an issue when using BCG since it is a measure of 
entire body vibrations rather than local chest vibrations. However, the main advantage of 
using SCG over BCG is the possibility of continuous monitoring, which can allow for 
monitoring in the context of normal stressors encountered by the person during their 
everyday activities (e.g., analyzing the changes in the SCG in response to exercise or other 
stressors as opposed to simply a once-per-day measurement by the scale). 
It is essential to study how research efforts cross domains from clinical to non-
clinical settings, and vice versa, to verify that both are congruent [57]. Therefore, we 
quantitatively study how the positioning of the accelerometer affects the slope and y-
intercept of this regression function (linking Q-AO to Q-B across subjects) and devise a 
method that enables the person using the wearable device to know whether or not the 
accelerometer is placed in the ideal (mid-sternal) position. Hence, the user will be able to 
adjust the positioning of the device and avoid computation of inaccurate estimates for the 
days on which the device is misplaced. This will be an important step in allowing ECG and 
SCG measurements to be used, for example, by HF patients at home for monitoring 




The study was conducted under a protocol reviewed and approved by the Georgia 
Institute of Technology Institutional Review Board (IRB). All subjects provided written 
consent before experimentation. Data were collected from ten healthy subjects: five 
females and five males (demographics: 24.7±2.3 years, 170±11.6 cm, 70±10.5 kg). The 
experiment was performed on two consecutive days. On the first day, each subject was 
asked to stand still for 60 seconds with accelerometers placed on the mid-sternum, 
approximately 7.5 cm to the right, and 7.5 cm to the left to obtain baseline measurements. 
The subject then performed a stepping exercise for one minute after which he was asked to 
stand still for 5 minutes to monitor the recovery. On the second day, the same protocol was 
repeated except the accelerometers were placed on the mid-sternum, 5 cm above, and 5 cm 
below (selected to be slightly less distance than the horizontal “misplacement” to closer 
simulate expected conditions in practice). On both days, ECG and ICG signals were 
collected as well. Figure 14(a) shows the sensor placement on both days combined and 
Figure 14(b) shows the SCG signals obtained from the different placements of 
accelerometers.  
3.2.2 Hardware Design 
The ECG and the ICG signals were measured using the same hardware described 
in section 3.1.2. To detect the small body vibrations in response to cardiac ejection (i.e., 
SCG signals), we used ultra-low noise and small-footprint 356A32 instrumentation 
accelerometers. The accelerometers are powered by the Model 482C15 sensor signal 
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conditioner (PCB, Piezotronics, Inc., Depew, NY). Only the signals along the dorsoventral 
direction from the accelerometers were analyzed in this study.  
3.2.3 Data Processing 
The SCG, ICG and ECG signals were filtered with an FIR Kaiser window band-
pass filters (cut-off frequencies: 0.8-30 Hz for SCG, 0.8-35 Hz for the ICG and ECG). The 
same method described in section 2.2.3 was used for ensemble averaging. 
 
Figure 14. a) Adapted from [58]. An illustration of the experimental setup. (b) A 450 ms 
portion of one ensemble averaged beat of an SCG signal collected from the accelerometer 
placed on the mid-sternal position vs SCG signals collected from the other accelerometers 
at rest. It can be observed that the waveforms are very different in their shapes and result 
in different estimations of the aortic valve opening (AO) and aortic valve closure (AC) 
points.  
3.2.4 Feature Extraction 
There is a lack of well-defined standards for the fiducial points of cardiomechanical 
signals, including SCG, due to how the morphology of the signal is affected by age, sex, 
and heart conditions. In a recent study, a delineation algorithm was designed to detect the 
fiducial points of the SCG signal, including the AO-point, by training an algorithm on 
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48,318 manually annotated cardiac cycles and resulted in good accuracy when tested on 
healthy individuals [59]. Additionally, many of the papers in literature detected the AO- 
point as the second positive peak of the SCG signal [33], However, we have found with 
our measurements, with standing rather than supine subjects, that this peak is not 
necessarily reproducible  from person to person, and the noise in the measurements can 
easily corrupt this peak’s detection as compared to the detection of the largest peak 
(positive or negative). Hence, to detect AO from the dorsoventral SCG signals, the timing 
of the minimum or maximum absolute magnitude in the first 200 ms is detected [60]. The 
B-point is detected as described in section 3.1.4.   
 
Figure 15. (a) The variation in AO and peak-to-peak amplitude of the DV SCG signal 
collected from mid-sternum as the physiological state of the subject changes between rest 
and exercise recovery. It can be noted that right after exercise the AO time decreases while 
the peak-to-peak amplitude increases only to stabilize back to baseline value as time passes. 
The five rectangles represent the AO and peak-to-peak values of the five waveforms shown 
in part (d) for the different physiological states. (b) A 450 ms portion of an ensemble 
average of DV SCG beats collected from the sternum during rest and different states during 
exercise recovery. We can observe that the waveforms look similar for a time shift and an 
increase in amplitude after exercise. 
Figure 15(a) shows how the AO and Peak-to-Peak values vary between the rest and 
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from one accelerometer location at different physiological states. The first waveform in 
Figure 15(b) is an SCG waveform taken when the subject is at rest while the rest of the 
waveforms are taken at different times during the post exercise recovery. The waveforms 
are identical in shape and the only change is a time shift to the left (i.e, AO and AC points 
occur at earlier times in the heart beat cycle) and an increase in the peak-to-peak amplitude 
of the waveform. By the end of exercise recovery, the SCG signal becomes identical to the 
original baseline rest SCG signal.  
3.2.5 Correlation During Rest and Exercise Recovery 
To quantitatively investigate how the change in the AO point of SCG for different 
accelerometer positions affects PEP estimation, a correlation analysis was performed 
between R-AO intervals and R-B intervals for the different sensor positions.  Every 6 beats 
of the signals at rest were averaged together to obtain ensemble averages with 50% overlap 
and every 10 beats of the signals during exercise recovery were also averaged together to 
obtain ensemble averages with 50% overlap. Six beats were sufficient for noise reduction 
when the subject was at rest, and was long enough to capture a typical respiratory cycle, 
while a higher number of beats was used for ensemble averaging during exercise recovery 
because of the increased postural sway as compared to rest. PEP (the timing at which the 
B-point – the opening of the aortic valve – occurs) was calculated. Additionally, the R-AO 
intervals of all SCG ensemble averages were calculated. Linear, quadratic and cubic 
regression were then performed with the y-value being the R-B interval (PEP) and the x-
value being the R-AO interval and the correlation coefficient r, was found for each type of 
regression.  
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3.2.6 Classification of Different Positions of Accelerometers 
To automatically determine when an accelerometer is placed in the desired, mid-
sternal, position or a different position, we implemented binary classification. This is done 
by extracting features from the SCG waveforms of all positions, labeling instances obtained 
from the mid-sternal SCG differently than instances obtained from SCG from other 
positions, dividing the instances we have into training and testing sets, and training a 
classifier on the training sets in order to predict the class of the instances in the test sets.  
The same ensemble averages of the SCG signals used for the AO point detection 
were used for extracting features from these signals; specifically, a set of 26 temporal and 
spectral features were extracted. Those features consisted of: mean, kurtosis, skewness, 
median, standard deviation, peak-to-peak (0-250 ms and 250-500 ms), RMS and peak to 
RMS ratio (0-250 ms and 250-500 ms) as temporal features and band power in the 
following bands (0-3 Hz, 3-6 Hz, 6-9 Hz, 9-12 Hz, 12-15 Hz, 15-18 Hz), 1st, 2nd and 3rd 
peak of the PSD, frequency of the 1st, 2nd and 3rd peak of PSD, mean of the PSD, kurtosis 
of the PSD, skewness of the PSD, and standard deviation of the PSD as frequency domain 
features. Table 4 shows the top features in terms of the average information gain provided 
by each feature, with information gain being a measure of the reduction in entropy (a 
measure of impurity) of the class variable after the value for the feature is observed, i.e.:  
      aTHTHaTIG ,  (7) 
where H is the entropy function, T are the training instances and α is the attribute (feature) 
in question [61]. The entropy function  XH , which is the expected number of bits needed 
to encode a randomly drawn value of X, is a measure of impurity of the set of training 
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Table 4. Best features in terms of information gain 
Info Gain Feature Feature Type 
0.053±0.014 Peak-to-Peak (1
st
 250 ms) Time 
0.049±0.011 Standard Deviation Time 
0.049±0.011 RMS Time 
0.046±0.007 1
st
 Peak of the PSD Frequency 
0.044±0.003 Mean of the PSD Frequency 
0.043±0.006 Peak-to-Peak (2
nd
 250 ms) Time 
0.043±0.005 Standard Deviation of the PSD Frequency 
 
Figure 16 is an illustration of some of those features in the time and frequency domain.  
The above mentioned features were extracted from SCG ensemble averages for all 
accelerometers’ positions for each subject. Instances from SCG acquired with an 
accelerometer in the mid-sternal position were associated with the label -1 while instances 
from all other positions were associated with the label +1. Multiple training and testing sets 
were created. For every subject to be tested, the training set included rest and exercise 
recovery instances from all other subjects, half the rest and exercise recovery instances 
from the SCG acquired with the accelerometer placed on the mid-sternum for that subject, 
and only rest instances from SCG acquired by accelerometers from all other positions for 
the tested subject. Four separate test sets were created with each of them consisting of the 
other half of the rest and exercise recovery instances of the mid-sternal SCG and the 
exercise recovery instances from SCG acquired by one of the differently placed 
accelerometers. This division resulted in a total of 10 training sets (one per subject) and 40 
test sets (4 per subject for each of the 10 subjects).  
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Figure 16. An illustration of some of the top features in the time and frequency domain. 
We exclude the exercise recovery instances from all positions different than the 
mid-sternal position from the training sets for the subject being tested, because we assume 
that we will not have that information when the device is initially calibrated for a particular 
subject. More specifically, when the subject wears the device for the first time under the 
supervision of a medical professional, it will be placed in the ideal position and several 
other positions for a duration of 60 seconds each. The subject (who may, for example, be 
a patient with HF at the index visit) will then be asked to perform the six-minute walk test 
[62] with the device placed in the mid-sternal position (which justifies using some of the 
exercise recovery data from the mid-sternal position). These initial measurements that are 
collected only when the patient uses the device for the first time, are used for calibration 
purposes, and hence, can be included in the training set. An illustration of the division of 
features into training and testing sets for one subject is shown in Figure 17.  
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Figure 17. The training and testing sets for training and testing the classifier on one of the 
subjects. The shaded areas are features that are excluded from the training set and included 
in the testing sets when trying to detect the sensor position for the subject. 
A boosted J-48 decision tree classifier with Adaptive Boosting algorithm was 
trained on each of the training sets and tested on the corresponding test sets for each subject 
to predict whether the SCG features are acquired from an accelerometer placed in the mid-
sternal position or other positions [63, 64]. There are many advantages for using the J-48 
Decision tree classifier as compared to other classifiers: 1) Decision trees are not sensitive 
to outliers since pruning is applied [61]; 2) Decision trees are non-parametric thus 
alleviating concerns about the data being linearly separable; 3) There is no need to tune 
different parameters as is the case with support vector machines, for example, which 
enables implementation of the same classifier for every subject; 4) Decision trees implicitly 
implement a form of feature selection by using the features with higher info gain as the top 











decision tree by running the classifier a number of iterations (10 in our case) and improving 
it by accounting for incorrectly classified instances from the training set at each iteration. 
3.3 Results and Discussions 
3.3.1 PEP and R-AO Correlation Results for SCG from Different Sensor Positions 
For each subject, the correlation coefficient resulting from the linear, quadratic and 
cubic regression between R-AO and PEP was calculated for every position. Results show 
high correlation for all positions which indicates that all positions are usable. However, 
each position, for the same subject, has its own unique regression curve relating to the B-
point of the ICG, and we need to have the initial regression parameters for each position 
and be able to detect exactly where the sensor is placed each day, which is not the case, in 
order to be able to use all the positions. Thus, if a person wears the device on successive 
days, and positions the device in different places on different days, even with the same 
underlying R-wave to aortic valve opening timing, the measurements from the SCG itself 
may be completely different and one would not know if the person’s underlying 
cardiovascular function changed, or if the device position changed, in comparing data from 
one day against the other. 
This demonstrates that a position detection algorithm is needed to distinguish 
whether the wearable device is placed on the mid-sternum or not. Specifically, using the 
initially calibrated parameters, obtained from the linear, quadratic, and cubic regression 
functions used with the mid-sternal SCG to estimate PEP, when the sensor is placed 
somewhere else, would result in inaccurate estimations.   
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A summary of the obtained correlation coefficients, r, averaged across all subjects 
is shown in Table 5 and the regression curves for one of the subjects when the 
accelerometer is placed on the mid-sternal position is shown in Figure 18. Additionally,  
Table 6 shows the average of absolute PEP estimation errors (ms) resulting from 
using the initially calibrated parameters obtained from the mid-sternal position when the 
accelerometer is placed in each of the 5 positions.  
 
Figure 18. Linear, quadratic and cubic regression curves for one subject with the 
accelerometer placed on the mid-sternal position   
 
Table 5. The average correlation coefficient (r) obtained from linear, quadratic, and cubic 
regression for the five different positions across all subjects. 
 
Correlation Coefficient (r) 
Linear Quadratic Cubic 
P1 0.96±0.027 0.96±0.042 0.97±0.038 
P2 0.94±0.084 0.98±0.024 0.99±0.006 
P3 0.95±0.048 0.96±0.049 0.96±0.049 
P4 0.96±0.032 0.96±0.042 0.97±0.035 























Table 6. Average absolute PEP estimation errors (ms) for each position 
 
 Subject Avg. 











 P1 2.5 3.4 5.8 1.2 5.0 2.7 2.9 2.0 5.9 4.2 3.6 
P2 4.8 4.7 16.7 5.3 52.9 10.9 27.9 10.1 167.1 6.3 30.7 
P3 22.6 6.5 8.7 11.8 79.8 10.7 105.4 35.9 107.1 5.8 39.4 
P4 24.9 10.4 60.4 18.1 46.3 15.2 28.5 54.9 5.2 21.3 28.4 













 P1 1.5 1.7 5.5 1.1 5 2.6 2.7 1.8 3.4 3.3 2.9 
P2 5.0 5.8 19 2.9 52.5 10.6 30.6 9.7 106.4 9.5 25.2 
P3 21.3 5.6 19.2 5.7 79.0 10.4 130.5 29.6 115.2 11.1 42.8 
P4 27.4 11.9 31.6 16.2 125.8 14.4 28.4 33.9 8.3 30.4 32.8 












 P1 1.4 1.6 5.2 0.9 4.2 2.4 2.5 1.7 1.8 3.3 2.5 
P2 5.1 5.9 16.2 3 345.8 11.3 20 6.5 150.1 8.4 57.2 
P3 38.0 6.1 18.9 5.6 830.3 10.6 222.8 46.2 143.7 10.5 133.3 
P4 24.7 11.7 472.6 15.2 78.1 14.0 17.9 101.1 7.5 16.8 76 
P5 8.1 12.8 22358.0 4.5 137.4 11.6 33.8 260.0 12.6 5.6 2284.4 
 
3.3.2 Classification Results 
To quantify the performance of the classifier, we used precision and recall as our 
metrics. Precision (or positive predictive value) is defined as the fraction of retrieved 
instances that are relevant while recall (or sensitivity) is defined as the fraction of relevant 
instances that are retrieved [65]. In other words, a recall of 1, would indicate that we are 
detecting every time the sensor is placed in any position other than the mid-sternal position, 
and a precision of 1 would indicate that all of those detected instances are actually in a 
position different than the mid-sternal one. Equations (9) and (10) are the mathematical 













  (10) 
where tp is the number of true positives (instances correctly classified as belonging to the 
undesired class), fp is the number of false positives (instances incorrectly classified as 
belonging to the undesired class), and fn is the number of false negatives (instances 
incorrectly classified as belonging to the desired class).  
With our classifier, we obtained a precision of 0.83 and a recall of 0.82. Considering 
that the classifier should return a +1 when a misplacement is detected and a -1 when no 
misplacement is detected, then, if the user is wearing the device every day of the year, i.e. 
365 days, and is placing it in a position other than the desired one 100 days, we will be able 
to detect the incorrect placement and notify the user on 82 of these days. On 17 of the 
remaining 265 days, the user will be incorrectly notified to check the position of the device. 
This inconvenience of having the patient double check the position of the device on 17 
days is insignificant when compared to the additional 82 days of correct PEP estimations 
that would have otherwise been inaccurate and could have potentially resulted in incorrect 
medical decisions. 
It is worth mentioning that gender based anatomical differences may impact the 
results for female subjects compared to male subjects. Hence, the training and testing of 
the classifier was performed again after excluding all instances related to positions 4 and 5 
in Figure 14(a), since they are the positions that are most likely to cause differences in 
signals based on gender and are also less likely to occur than positions 2 and 3. The results 
obtained were a precision of 0.83 and a recall of 0.81, which indicates that the inclusion or 
exclusion of those positions does not affect the results by much. 
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Figure 18. (a) The best feature in terms of info gain (Peak-to-Peak in the 1st 250 ms) plotted 
against the 3rd feature (RMS) for above sternum SCG compared to mid-sternum SCG in 
one of the test sets (b) The 2nd feature (Standard deviation) plotted against the 4th feature 
(1st peak of the PSD) for above sternum SCG compared to mid-sternum SCG in one of the 
test sets. It is clear in both (a) and (b) that those features result in two distinct clusters for 
these two positions which indicates that the position of the sensor (accelerometer) can be 
accurately detected. 
  From Table 6, we can observe that for subject 4, for example, calculations of PEP 
detection error resulted in an absolute average error of 1.2 ms when the device is correctly 
placed, 18.1 ms when it is placed to the right of the sternum, 6.7 ms when it is placed to 
the left of the sternum, 5.3 ms when it is placed in an upper-sternum position, and 11.8 ms 
when it is placed in a lower-sternum position. Each of these errors can be reduced to an 
average error of 1.2 ms in PEP estimation every time a wrong placement of the wearable 
device is detected. One should consider the possibility that day-by-day measurements 
would be compared against one another, but that the subject would position the device 
differently from one day to the next. In this case, having a different placement would lead 
to the R-AO interval meaning something very different on day 2 compared to day 1, etc.  
 It is also worth noting that the peaks that characterize the SCG waveform shape 






































even identify the main peaks of the waveform in certain positions. Therefore, detection of 
SCG sensor misplacement could also be useful for improving the robustness of SCG 
measurements in unsupervised settings overall, for parameters beyond PEP. 
 Figure 18(a) and Figure 18(b) show a clear separation of features from instances 
from a mid-sternal SCG compared to those of an above sternum SCG in the form of two 
distinct clusters. 
3.4 Conclusions 
We have shown that when SCG is used for PEP estimation, placing the 
accelerometer on different positions on the chest area results in different regression 
parameters (different slopes and intercepts). Hence, using the already calculated regression 
parameters from an SCG measured from the ideal position (mid-sternal position), for a 
certain subject, would result in inaccurate PEP estimates if the sensor is placed in a slightly 
different position. Therefore, we devised a method to detect when the sensor is placed in a 
position different than mid-sternum, in order to be able to provide feedback to the user to 
re-position the wearable device and avoid inaccurate measurements (or use the information 
regarding incorrect placement in post-processing to analyze the data accordingly).  
In a practical scenario, when the wearable device is used by an HF patient, an initial 
calibration will be conducted first under the supervision of a medical professional, to 
calculate the regression parameters and obtain the training instances. After that, the patient 
will be wearing this device every day, which would enable the physicians to continuously 
monitor the patient’s PEP, and as a result, the contractility of his heart. Additionally, the 
patient will be warned when the algorithm detects a sub-optimal placement of the device 
and will be asked to reposition it to guarantee accurate estimation of PEP. Such estimations 
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of PEP at home, in particular in response to activity, can potentially allow early detection 
of decompensation, and the changing of therapies to avoid hospitalization.  
This chapter solves the issue of detecting the misplacement of the SCG sensor, and 
hence, avoiding inaccurate PEP estimation and wasted measurements. However, this does 
not eliminate the cause of the problem, which is that the morphology of the SCG signals 
changes with different placements, therefore changing the AO-point that is used to estimate 
PEP. If PEP can be estimated without relying solely on AO-point detection, but rather on 
multiple features extracted from the signal, then these estimates would be more robust to 
positioning changes. This is the motivation behind the work presented in the next chapter. 
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CHAPTER 4. UNIVERSAL PRE-EJECTION PERIOD 
ESTIMATION USING SEISMOCARDIOGRAPHY: 
QUANTIFYING THE EFFECTS OF SENSOR PLACEMENT AND 
REGRESSION ALGORITHMS 
4.1 Introduction 
An important limitation of SCG signals remains: SCG waveforms vary 
significantly from person to person which makes it difficult to accurately detect the “AO” 
point, and thus extract an absolute measure of PEP (i.e., the R-AO interval). Figure 19 
shows three example SCG waveforms from different subjects with simultaneously 
obtained ICG signals. While the standard approach based on the existing literature is to 
denote the AO point as the second main peak of the SCG signal following the R-wave of 
ECG, this point does not occur concurrently with the “reference-standard” aortic valve 
opening point from the ICG signal (the B-point). For patients with HF, even greater 
variability is observed in the shape of the SCG waveform from person to person, thus 
motivating the need for improved methods for universal PEP estimation from SCG 
waveforms.  
In this chapter, we set forth a novel approach to detecting the AO point from SCG 
recordings. Rather than searching for a single peak in the signal that corresponds to the 
aortic valve opening, we extracted multiple timing features from the SCG signal and 
combined all the detected features to create a universal regression model that predicts the 
relationship with the B-point in the ICG, across all subjects. We also quantified the effects 
of sensor location on the quality of PEP estimation to provide data-driven 
recommendations on optimal placement for minimizing PEP estimation error. 
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Figure 19. ICG and dorsoventral SCG ensemble averaged traces (n = 5 heartbeats) obtained 
with the sensor on the sternum for three different subjects. The ICG B-points and SCG 
AO-points are marked with red circles, and there is a substantial time difference between 
the two corresponding points for the three subjects: in two cases, the ICG B-point occurs 
first, and in the third case the SCG AO-point occurs first. 
4.2 Methods 
4.2.1 Protocol 
The study was conducted under a protocol reviewed and approved by the Georgia 
Institute of Technology Institutional Review Board (IRB). All subjects provided written 
consent before experimentation. Data were collected from 10 healthy subjects, 5 males and 
5 females (demographics: 23±3.3 years, 168.1±10.4 cm, 64.1±11.8 kg).  
The experiment was divided into three parts with 15-minute breaks in between the 
parts. In each part of the experiment, the subject was asked to stand still on the BCG scale 
for one minute, then perform a stepping exercise for one minute, then stand still on the 









































one on each of the mid-sternum (Str), point of maximum impulse (PMI), below the left 
clavicle (LC) and below the right clavicle (RC). In part II, two accelerometers were coupled 
with a rigid plastic mold that was placed on the sternum such that the sensors were on the 
upper sternum (US) and lower sternum (LS). Finally, in part III, one accelerometer was 
placed on a flexible silicone sheet which was placed on the sternum such that the 
accelerometer was on the mid-sternum (FStr). In addition to BCG and SCG, we also 
measured electrocardiogram (ECG) signals, whose R-peaks were used as timing references 
for beat segmentation, and ICG signals, whose B-points were used as the reference standard 
timing for aortic valve opening. Figure 20(a) shows the placement of the electrodes and 
accelerometers in part I of the experiment. The purpose of part I of the experiment was to 
determine the location or combination of locations for SCG that provide the best PEP 
estimates. Parts II and III in combination with the sternum-placed accelerometer from part 
I are used to determine the best interfacing method of the sensors with the body. 
4.2.2 Hardware and Data processing 
To measure SCG signals, ADXL354 low noise, low drift, low power 3-axis 
accelerometers were used. The accelerometers were placed in a plastic case 2.8 cm wide 
and 3 cm long (shown in Figure 20(a)). The outputs of the accelerometers were connected 
to the data acquisition system (MP150, BIOPAC System, Inc. Goleta, CA). For part II of 
the experiment, two of the ADXL354 accelerometers in the plastic casing were placed in 
custom-made rigid acrylonitrile butadiene styrene (ABS) plastic mold that is 12.7 cm long 
with a 5.1 cm spacing between the accelerometers. For part III of the experiment, one of 
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the accelerometers in the plastic casing was placed on a silicone rubber sheet with 





















































































Figure 20. (a) The experimental setup for Part I of the experiment. Four ADXL354 
Accelerometers are placed on the subject, one each at the mid-sternum, below the left and 
right clavicle, and at the point of maximal impulse. ICG and ECG signals are collected 
simultaneously. (b) Five beat ensemble averaged traces of ECG, ICG and mid-sternum 
dorsoventral SCG heartbeats. The ECG R-peak is used as a reference point for beat 
segmentation, the B-point of the ICG is used to detect aortic valve opening and the R-B 
interval is used as the ground truth PEP. Peak timing locations and width are extracted 
from the SCG signal as shown. (c) After extracting the features from the head-to-foot and 
dorsoventral axes of the SCG signals from all locations, a regression model is used to obtain 
PEP estimates from the features obtained from a single location, multiple combination of 
locations, one axis, and both axes. RMSE between the ground truth PEP and every estimate 
is calculated and the optimal location / combination of location and axes is determined.   
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and 0.16 cm thickness. The different interfaces are shown in Figure 21(a).  
To measure ECG and ICG, BN-EL50 and BN-NICO wireless modules (BIOPAC 
System, Inc. Goleta, CA) were used and to measure BCG the modified electronic weighing 
scale (BC534, Tanita, Tokyo, Japan) that was developed in [47] was used. All signals were 
sampled at 2 kHz. 
The SCG, ICG, ECG and BCG signals were filtered with an FIR Kaiser window 
band-pass filters (cut-off frequencies: 0.8-30 Hz for the SCG, 0.8-35 Hz for the ICG, 0.8-
40 for the ECG, and 0.5-20 Hz for the BCG). 
4.2.3 Feature Extraction 
Heart beats segmentation was performed as described in section 2.2.3. Every five 
beats from each of the SCG, BCG, and ICG signals were averaged together to reduce the 
noise, and an overlap of four beats between consecutive ensemble averages was used to 
maximize the number of ensembles. This made up a total of 6084 ensemble averages across 
all 10 subjects. 
The B-point (inflection point) of the ICG was extracted as described in section 
2.2.4. The following features were extracted from the z-axis (dorsoventral) and x-axis 
(head-to-foot) SCG ensemble averages from every location for all subjects: first and second 
maxima locations (0-250 ms), first and second maxima width (0-250 ms), first and second 
minima location (0-250 ms), first and second minima width (0-250 ms), first maximum 
location (250-500 ms), first maximum width (250-500 ms), first minimum location (250-
500 ms), first minimum width (250-500 ms). Thus, a total of 12 features per axis for each 
sensor placement were extracted. We picked timing features from the early portion of the 
signal (0-250 ms) in order to captures events related to the aortic valve opening. Rather 
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than calculating only the R-AO interval, we explored a number of peaks timings and widths 
as these timings might also be related to cardiac mechanics. Additionally, although it is the 
timing features from the systolic portion of the signals that are related to PEP, we decided 
to explore the diastolic portion as well by adding peak timings and widths from the later 
portion of the signals (250-500 ms). The features are illustrated in Figure 20(b). 
4.2.4 Regression Model 
To estimate the PEP using the features extracted from the SCG signals, we trained 
a regression model. For every accelerometer placement, M features extracted from N 
ensemble averages were placed in an MN   matrix X while the corresponding PEP values 
are placed in an 1N  vector PEPy . These were then used to train a regression model which 
learns the relationship between X  and PEPy . The learned model can then be used to 
estimate PEP for new heartbeats, given the features extracted from the SCG signals. 
Many previous studies that utilize SCG signals to estimate hemodynamic 
parameters use linear regression to relate the SCG features to the estimated parameter [35, 
41, 60, 66]. However, it is possible that the relationship between PEP and SCG features is 
not necessary linear, as is often the case in real data sets [67]. Therefore, rather than using 
only linear techniques, we chose to exploit recent advances in the field of machine learning: 
specifically, in this work, we used Extreme Gradient Boosting (XGBoost) regression which 
is a relatively new algorithm that has recently gained popularity as it is a computationally 
efficient implementation of a powerful ensemble learning technique [68]. XGBoost is an 
implementation of the gradient boosting machine learning algorithm [69]. This falls under 
a category of learning algorithms called ensemble methods, which combines multitudes of 
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estimators to predict a variable rather than using a single estimator [70]. XGBoost trains 
many regression trees iteratively, where new models predict the residual errors of previous 
ones and are then added together.  
Specifically, let x  be a vector containing all features extracted from one ensemble 
in our dataset. Let  xh  denote a regression tree, which partitions the feature space into 
pieces and assigns a constant to each partition [71]. XGBoost trains many regression trees 
 xmh  in a consecutive manner, and adds them up such that the cumulative model  xmf  
at iteration m is: 
      xxx mmm vhff  1  (11) 
 xmh  is trained to predict the error residuals between  xmf  and the target variable. The 
hyperparameter v is referred to as the learning rate and has the effect of shrinking the 
contribution of each individual tree  xmh , thus reducing the risk of overfitting [69]. Each 
regression tree is trained on a randomly sampled subset of the ensembles (rows of X ) and 
features (columns of X ). This introduces two hyper-parameters which are the factors by 
which the rows and columns of X are sampled. 
 Furthermore, while training the regression tree  xmh , the weights assigned to each 
partition of the feature space are L2 regularized using a regularization hyper-parameter λ. 
Row and column subsampling as well as regularization has been reported to increase model 
accuracy and decrease overfitting [68-71]. The final regression model  x
b
M
f  emerges 
after bM stages of iteratively applying equation (11), where bM  is referred to as the number 
of boosting rounds.  
 53 
 We used XGBoost regression to estimate PEP using SCG signals from different 
sensor locations. Estimated PEP results from different sensor locations were compared 
using a variation of the repeated cross-validation model assessment method discussed in 
[72].  
Given that our dataset consists of 10 subjects, we first randomly paired these 
subjects into five groups. We then performed cross-validation by leaving one group (two 
subjects) out at each fold. At each fold of the cross-validation, we trained an XGBoost 
regressor on the data from all subjects except the ones that were left out. We predicted PEP 
for the left-out subjects and repeated this four more times to have PEP predictions for all 
ensembles from all subjects. We then calculated the root mean squared error (RMSE) 
between the estimated and ground truth PEPs. The entire process was repeated 50 times 
with a new random pairing of subjects each time. We calculated the cross-validation RMSE 
as the average of the RMSE scores from 50 repetitions. This approach was repeated for 
different SCG sensor locations and compared the resulting RMSE scores. We also 
combined pairs of sensor locations in order to explore which combination of two locations 
yields better PEP estimates. This was performed by combining features from a pair / 
multiple combinations of sensor locations and running the cross-validation procedure for 
different pairs / combinations of locations. We repeated this procedure using features only 
from the z-axis (dorsoventral), and both z+x axes combined (dorsoventral + head-to-foot). 
Single and multiple sensor comparisons were supported using statistical analysis of the 
cross-validation results which are described below in section 4.2.10. Using this approach, 
a global model was trained rather than multiple subject-specific models.  
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 We performed this cross-validation procedure rather than using a leave one subject 
out cross-validation (LOSO-CV) to minimize the risk of overfitting the model to the dataset 
[73]. In LOSO-CV, only one subject is left out at each fold. Therefore, the training sets at 
each fold do not differ significantly. Leaving more subjects out leads to more variety in the 
training sets at each fold, and thus improves the generalizability of the resultant regression 
model. Additionally, there are many ways in which subjects can be grouped into pairs for 
leave-two-subjects-out cross-validation. To mitigate dependency on this grouping, we 
repeat the cross-validation 50 times with different pairing at each repetition. 
4.2.5 SCG Sensor Location Comparison 
To compare different SCG sensor locations, we trained XGBoost regressors on 
SCG features acquired from the different locations on the body. We assessed the ability of 
a sensor location in estimating PEP by calculating the (RMSE) between the estimated PEP 
values i)(























where N is the number of ensembles. Figure 20(c) shows a high-level block diagram of the 
process.  
All XGBoost regressors trained for sensor location and axis comparison have the 
following hyper-parameter settings: learning rate=0.1, number of boosting rounds=200, 
column sampling factor=0.5, row sampling factor=0.5, regularization parameter (λ)=1. 
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These parameters were selected heuristically and the sensitivity of our results to them is 
analyzed in section 4.3.4. 
4.2.6 Rigid vs. Flexible Interfacing Material Between the SCG Sensor and Sternum 
To compare different methods of interfacing the SCG sensor to the sternum, we 
calculated the cross-validation RMSE scores by repeating the procedure explained in 
section 4.2.4 on signals acquired by placing the accelerometer (1) directly on the sternum; 
(2) placing two accelerometers on the upper and lower sternum using a rigid custom sensor 
housing; and (3) placing flexible material between the accelerometer and the skin. The 
process was repeated using only the z axis of the sensors and combining both z+x axes. 
For the rigid custom housing, we compared PEP estimates obtained using only the 
accelerometer placed on the upper sternum, only the lower sternum and combining both 
locations. Comparisons of different sensor interfacing methods were supported using 
statistical analysis as explain in section 4.2.10. The SCG signals obtained from the different 
interfaces are shown in Figure 21(b). 
4.2.7 Feature Importance Evaluation 
While evaluating different SCG sensor locations and interfacing methods, we 
trained XGBoost regressors using many features acquired from one or multiple sensors and 
axes as shown in Figure 20(b). However, only a portion of these features is relevant. The 
XGBoost regressor (like any other gradient boosting tree) trains regression trees which can 
be used to rank the features according to importance. Typically, the deep nodes of a tree 
divide using less important features while the main (first) node divides on the most 
important feature. The importance of features obtained from all trees are averaged resulting 
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in the final relative feature importance scores, which can then be used to rank the features. 
Mathematical details of the feature importance scoring and ranking are explained in detail 
in [71].   
 
Figure 21. (a) Different methods of interfacing the ADXL354 accelerometer with the 
sternum. (b) SCG signals obtained from each of the different interfacing materials. 
In order to evaluate which features generated from the SCG signals were more 
relevant in estimating PEP, we trained an XGBoost regressor on the pair of sensor 
combination and axis that gave the best PEP estimates (left clavicle + sternum, z-axis). All 
data from every subject were used to train the regressor and the resulting model was used 
to generate relative feature importance scores as described above. It should be noted that 
no testing set is required to score feature importance as we are not evaluating 
generalizability of the model for this portion of the study. 
4.2.8 Comparing Different Regression Techniques 
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We hypothesized that XGBoost regression would perform better than linear 
regression models as well as other non-linear regression models. To address our 
hypothesis, we compared results obtained using SCG sensors (z-axis only) placed on the 
left clavicle and sternum (sensor placement combination with lowest cross-validated 
RMSE) and XGBoost regression to the same sensor placement combination (same feature 
set) but using simple multiple linear regression. This method uses ordinary least squares 
[71] and is the regressor of choice for previous related work [35, 41, 60, 66].  
An extension of ordinary least squares regression is Ridge regression which 
penalizes regression coefficients by utilizing L2 regularization to reduce overfitting [74]. 
This regression model is still linear but the L2 regularization results in some coefficients to 
shrink, where the amount of shrinkage is controlled by a parameter αridge. Setting αridge=0 
is identical to ordinary least squares regression and coefficients are more heavily shrunk as 
αridge is increased. We assessed the performance of this regression technique as well on our 
dataset by training Ridge regression models with αridge ranging from 10
-3 to 102 
logarithmically, keeping the feature and data set the same as explained above.  
Another variant of ordinary least squares regression is Lasso regression which uses 
L1 regularization to shrink regression coefficients via a regularization parameter αLasso [75]. 
Compared to Ridge regression (which utilizes L2 regularization), Lasso tends to produce 
sparser linear models where many coefficients can be reduced to zero, which results in a 
form of feature selection. We also trained Lasso regressors on the same dataset varying 
αlasso logarithmically from 10
-3 to 102. 
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XGBoost is an ensemble method combining many base estimators [68]. Ensemble 
methods using regression tree estimators can fit complicated non-linear functions robustly, 
which might result in better estimations compared to linear models such as ordinary, Ridge, 
or Lasso regression. We compared XGBoost to two other ensemble regression methods: 
random forest regression and Extra-Trees regression. 
Random forest regression like XGBoost trains many regression trees but unlike 
gradient boosting, each trained tree is independent. Trees are trained on a sample drawn 
with replacement and on a random subset of features [76]. Extra-Trees regression is similar 
to Random forest regression but adds more randomness to the model. 
While Random forest tree nodes are divided using the most discriminative 
threshold, in Extra-Trees, a subset of thresholds is chosen for each feature and the best 
combination of these random splits are chosen [77]. We assessed the performance of 
Random forest and Extra-Trees regression on our dataset where regressors contain 200 
trees and column sampling factor is chosen as 0.5 similar to XGBoost model parameters. 
Each tree was trained on a subset of features consisting of featuresn  features. 
We compared the cross-validated RMSE resulting from the different regression 
models using the cross-validation procedure explained in section 4.2.4. The features and 
dataset were kept the same and only the regression technique was altered.  
4.2.9 Evaluating the Effect of XGBoost Hyperparameters 
Our choice of XGBoost hyperparameters as explained in section 4.2.4 was 
heuristic; however, variations of these parameters may alter results. An algorithm can be 
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considered robust if changes in hyper-parameters do not alter the results greatly. Contrarily, 
if small perturbations in parameters cause large variations in results, the algorithm might 
not generalize well due to sensitive dependence on the choice of parameters.  
We evaluated the dependence of results on the learning rate by varying this 
parameter on a logarithmic grid of 50 points ranging from 10-2 to 100. We evaluated the 
cross-validated RMSE as explained in section 4.2.4 on the feature set derived from the 
SCG signals acquired from the left clavicle and sternum (z-axis), for each of 50 different 
learning rates, keeping everything else constant. We repeated this for 50 column sampling 
factor values on a linear grid from 0.1 to 1.0, 50 row sampling factor values on the same 
grid, and 50 regularization parameters (λ) on a logarithmic grid ranging from 10-2 to 101. 
While varying each parameter, we set all other parameters constant at the values described 
in Section 4.2.4. 
4.2.10 Statistical Analysis 
We performed statistical analysis on the cross-validated RMSE results to compare 
various SCG sensor locations. We performed leave two subjects out cross-validation 50 
times and calculated RMSE for each repetition. In each of the 50 repetitions, the subjects 
were paired randomly, and this process was repeated for different sensor locations and 
combinations of locations. The random seed was fixed so that in the jth repetition, the 
subjects were paired in the same way for all sensor locations/combinations. RMSE results 
from the 50 repetitions were compared using multiple comparison statistical testing for 
different locations and combinations. The Friedman Test was used to detect if any 
differences exist. For post-hoc testing, Wilcoxon signed rank test was performed on pairs 
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of sensor locations / combinations to be compared. Benjamini-Hochberg correction for 
multiple comparison was performed on the p-value from the post-hoc testing. These 
statistical tests and the reasons they should be used to compare machine learning models 
are discussed in detail in [78]. A similar procedure was followed to compare different 
sensor interfacing methods statistically. P-values below 0.05 were considered statistically 
significant. 
4.3 Results 
4.3.1 Comparison of Different Sensor Locations 
Results comparing RMSE in milli-seconds (ms) from the SCG signals obtained 
from accelerometers placed on sternum, PMI, below the left clavicle and below the right 
clavicle, and every combination of these accelerometers for both the dorsoventral (z-axis) 
and the head-to-foot combined with the dorsoventral axis (z+x) are shown in Table 7. 
Statistically significant differences exist in these results according to Friedman test 
(P<0.05). To investigate where the significance exists, Wilcoxon signed rank test was 
performed on the different pairs of locations/combination of locations.  
When comparing single locations, results showed that the z-axis of the signals from 
the sensors placed below the left and right clavicle provided the least RMSE in PEP 
estimates with 13.4±0.4 ms and 13.2±0.4 ms respectively (Figure 22(a), P<0.05 according 
to the Wlicoxon signed rank test comparing RC and LC to sternum and PMI). Additionally, 
features from head-to-foot SCG did not add substantial information to dorsoventral SCG 
features for all the signals except LC SCG, whose RMSE improves from 13.4±0.4 ms to 
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12.4±0.5 ms by combining the dorsoventral and head-to-foot features (P<0.05 according 
to Wilcoxon signed rank). 
 
Figure 22. (a). RMSE from PEP estimated from features obtained from accelerometers 
placed on the sternum (Str), point of maximal impulse (PMI), below the left clavicle (LC), 
and below the right clavicle (RC) for both the dorsoventral axis (z-axis) and head-to-foot 
and dorsoventral axes combined (z+x axes). (b) RMSE from PEP estimated from features 
obtained from the best performing combination of accelerometer locations. It can be 
observed that adding more sensors does not substantially reduce the error obtained using 
one sensor below the left or right clavicle.  
When combining features from signals from multiple locations, the best performing 
combination was the dorsoventral SCG from the sternum and LC with RMSE=11.6±0.4 
ms (P<0.05 with every single location and combination except the combination of all 
sensors z-axis, Wilcoxon signed rank). Adding features from other locations and axes to 
the z-axis of these two locations did not improve the estimation (Figure 22(b)). 
This best combination of signals (sternum+LC z-axis) was used in the feature 
importance analysis as described in Section 4.2.7. The results show that the timing of the 
first maximum of the dorsorventral LC SCG signal (0-250 ms) is the most important feature 
used in the XGBoost trees. Out of the top 15 features, nine features belonged to the LC 
































SCG signals and six belonged to the sternum SCG signal. The top 15 features are shown 
in Figure 23. 
 
Figure 23. Ranking of best 15 features obtained from the combination of sensors and axis 
that rendered the lowest RMSE (Str+LC axis z).  
Table 7. RMSE (ms) for PEP estimates from SCG signals measured from sensors placed 
in different locations (Str, PMI, LC, RC) 
Location z-axis RMSE z+x axes RMSE 
Str 16.42±0.71 16.30±0.65 
PMI 17.13±0.56 17.47±0.64 
LC 13.36±0.44 12.37±0.47 
RC 13.23±0.42 13.35±0.45 
Str+PMI 14.61±0.51 15.29±0.61 
Str+LC 11.60±0.36 11.98±0.56 
Str+RC 13.55±0.56 14.10±0.50 
PMI+LC 13.12±0.49 12.57±0.46 
PMI+RC 13.01±0.31 13.85±0.46 
LC+RC 11.96±48 12.40±0.51 
Str+PMI+RC 13.27±0.40 13.69±0.48 
Str+PMI+LC 12.04±0.38 11.93±0.28 
Str+RC+LC 11.97±0.42 12.37±0.46 
PMI+RC+LC 12.19±0.50 12.84±0.49 
Str+PMI+LC+RC 11.76±0.45 12.42±0.37 
4.3.2 Comparison of Different Sensor Interfacing Material 
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Results comparing RMSE in ms from SCG signals obtained from accelerometers 
placed on the sternum directly (Str), using a flexible silicone rubber sheet (FStr), and using 
a rigid plastic mold coupling two accelerometers on upper and lower sternum (US and LS) 
are shown in Figure 24. Statistically significant differences exist in these results according 
to Friedman test (P<0.05). To investigate where the significance exists, Wilcoxon signed 
rank test was performed on the different pairs of interfacing methods.  
 
Figure 24. RMSE from PEP estimated from accelerometers placed on the sternum with 
different interfacing techniques: directly on the sternum (Str), in the middle of a silicone 
rubber sheet placed along on the sternum (fstr) and two accelerometers coupled by a rigid 
plastic mold and placed on the upper sternum (US) and lower sternum (LS) 
Placing the accelerometer on the flexible silicone rubber sheet rather than directly 
on the sternum did not reduce the accuracy of the PEP estimates obtained from the SCG 
signals compared to placing the accelerometer directly on the sternum and even slightly 
improved it (16.0±0.6 ms vs. 16.4±0.7 ms respectively for the z-axis, P<0.05, Wilcoxon 
signed rank test; and 15.6±0.6 ms vs. 16.3±0.6 ms respectively for the z+x axes, P<0.05, 
Wilcoxon signed rank test). On the other hand, coupling the accelerometers using a rigid 
mold significantly reduced the accuracy of the PEP estimates obtained from these signals 

















even when features from both accelerometers placed on the upper and lower sternum were 
combined (P<0.05 when compared to str and fstr, Wilcoxon singed rank test). 
4.3.3 Comparison of Different Regressors 
When different regression techniques were compared keeping the feature set the 
same, it was observed that XGBoost produced the lowest RMSE as expected (Figure 25, 
P<0.05 according to Friedman test and P<0.05 when comparing XGBoost to all other 
regressors, Wilcoxon singed rank test). Compared to XGBoost, ordinary least squares 
regression resulted in an RMSE that was 8 ms higher. Introduction of L2 regularization via 
Ridge regression does not improve linear regression results. Figure 25 shows results only 
for αridge=1, but results did not alter substantially for the range of αridge values tested. L1 
regularization via Lasso regression improves linear regression RMSE results by around 2 
ms (P<0.05, Wilcoxon singed rank test), however, this is still substantially greater error 
than corresponding RMSE results using XGBoost. 
 
Figure 25. Comparing RMSE for PEP estimates obtained using ensemble regression 
models vs. linear regression models on features obtained from SCG signals that performed 
best with XGBoost (i.e., LC+sternum z-axis). 



















In Figure 25, ensemble learning methods have been highlighted in green while 
linear methods are shown in blue. As hypothesized, ensemble methods produce lower 
RMSE when compared to generalized linear methods. Out of the ensemble methods, we 
find that random forest regression performs better than Extra-Trees regression (P<0.05, 
Wilcoxon signed rank test), while XGBoost maintains the best performance. 
4.3.4 Effect of XGBoost Hyperparameters 
Figure 26(a) shows the variation in cross-validated RMSE as the learning rate is 
varied. The variations in RMSE for learning rates in the range 2×10-2 to 4×10-1 is minimal. 
However, learning rate must not be increased or decreased too much, as values above 0.4 
and below 2×10-2 lead to deterioration in RMSE.  
Figure 26(b) shows the effect of varying the column sampling factor on the RMSE. 
It can be seen that for values between 0.4 and 1.0, the variation in RMSE is minimal but 
for values below 0.4, RMSE deteriorates.  
 
Figure 26. (a) RMSE for PEP estimates obtained using XGBoost on features obtained from 
LC+sternum z-axis while varying the learning rate parameter (b) RMSE for PEP estimates 
obtained using XGBoost on features obtained from LC+sternum z-axis while varying the 

































We also investigated the effect of varying the row sampling factor and the 
regularization parameter on RMSE as discussed in section 4.2.9. Varying these parameters 
within the ranges explained in section 4.2.9 lead to nearly no changes in RMSE (<1 ms 
change in RMSE).   
4.4 Discussion 
Our universal regression model showed, for the first time, that SCG signals collected 
from below the left or right clavicle provide better PEP estimates than those collected from 
the sternum. To understand why LC and RC features perform better than sternum and PMI, 
we calculated Spearman correlation between the top 3 features from every location and the 
I-wave, J-peak, and K-point of the weighing scale BCG. The reason we perform this 
correlation is that it has been demonstrated that BCG, which represents total body 
displacement from the heart beats is a good alternative to ICG for measuring PEP [30]. 
Results showed no correlation between the sternum and PMI features with BCG features 
and good correlation between LC and RC features with BCG features, specifically J-peak 
and I-wave (Figure 27). Hence, it can be inferred that SCG signals obtained from below 
the left and right clavicle are more representative of total body displacement from the heart 
beats than SCG obtained from sternum and PMI.  
Additionally, when examining the top features from the best combination of signals 
(sternum + LC), most top features were from LC SCG rather than from sternum SCG, 
which can be attributed to the fact that LC performs better than the sternum in terms of 
PEP estimation error for our dataset.  
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Beyond providing insight into sensor placement, the regression models differentiated 
the effects of different interfacing methods. Finding that SCG obtained from placing the 
sensor on a silicone rubber sheet performs as well, and even slightly better, in PEP 
estimation than SCG obtained from placing the sensor in direct contact with the skin could 
be an indication that the sensor can be worn over a thin layer of clothing (tightly fitted over 
the body to ensure good coupling of the sensor to the skin) without affecting the 
measurements. This is an important finding that supports the practicality of a wearable 
SCG device, and warrants further investigation. 
 
Figure 27. Spearman correlation between the top 3 features from signals from every 
location and the I-wave, J-peak, and K-point of scale BCG. There was almost no correlation 
between sternum and PMI features with BCG features while good correlation was obtained 
between RC and LC features with BCG features and specifically the I-wave and J-peak. 
(highlighted with the red boxes). 
Furthermore, we demonstrated in this paper that the relation between the extracted 
features and PEP is better characterized by non-linear models rather than linear ones. 
Ensemble methods, were shown to model non-linear relationships between the predictors 
and PEP well [70]. Ensemble methods also attempt to perform automatic feature selection 










intrinsic feature selection using L1 or L2 regularization [71, 76]. In general, ensemble 
learners produce powerful estimators as they combine a diverse set of models. Each 
regression tree in the ensemble is built by randomly subsampling instances and features. A 
committee of these models is robust (reduced variance) and generalizes well [75].  
From the examined linear regression methods, introducing L1 regularization via 
Lasso regression slightly improved the linear regression while L2 regularization via Ridge 
regression did not. This can be attributed to the fact that there is a large number of features 
and L1 regularization produces better intrinsic feature selection (via shrinkage) than an L2 
penalty. On the other hand, from the examined ensemble regression methods, Extra-Trees 
regression performing worse than random forest regression can be linked to the increased 
randomness in determining tree node division thresholds in Extra-Trees which might 
account for the degradation in performance. Finally, XGBoost performed best, possibly 
because each tree in the ensemble is iteratively trained according to the prediction errors 
of previous trees, whereas the other methods train independent trees. XGBoost also 
regularizes each tree in the ensemble to improve generalization and reduce overfitting, 
which is not performed in random forests or Extra-Trees.  
A drawback of XGBoost compared to the other techniques considered is the 
abundance of hyperparameters to tune. However, the performance was found to be robust 
to changes in hyperparameters as variations in the regularization parameter row sampling 
factor, and in learning rate even by an order of magnitude caused infinitesimal variation in 
RMSE. Large values of the learning rate mean that each tree in the gradient boosting 
ensemble contribute more to the model which reduces the regularization effect, rendering 
the trained model more prone to overfitting. On the other hand, as the learning rate is 
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decreased, each tree’s contribution decreases and in the extreme of a null learning rate, the 
consecutive trees do not contribute to the mode at all, meaning the gradient boosting is no 
longer performed. Therefore, a learning rate value > 0.4 or < 2×10-2 resulted in deterioration 
in RMSE. Finally, when varying the column sampling factor, values below 0.4 worsened 
the RMSE, because as the column sampling factor decreases, increasingly smaller subsets 
of the features space are used to train each tree in the ensemble. 
In general, our method was robust to changes in hyperparameters, and thus we did 
not perform hyperparameter tuning. While hyperparameter tuning via extensive grid search 
or random search can likely lead to improvement in RMSE, this approach would also be 
very time consuming and computationally expensive. Robustness to variations in the 
hyperparameters also means that the gains due to tuning might be relatively small 
compared to gains due to better sensor positioning. 
4.5 Conclusions and Future Work 
In this chapter, we developed universal regression models to estimate PEP from SCG 
signals measured from multiple locations and compared the outputs of the resulting 
regression models by calculating the RMSE between the estimated PEP values with the 
ground truths PEP values obtained from ICG. We demonstrated that ensemble regression 
models provide significantly more accurate PEP estimates than linear regression models. 
Additionally, in our dataset, we showed, for the first time, that placing an accelerometer 
below the right or left clavicle results in better PEP estimates than placing the 
accelerometer on the sternum, which is the common placement in SCG literature. We also 
found that SCG signals obtained from below the left and right clavicle are more 
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representative of total body displacement from heart beats as their features were better 
correlated with BCG features than sternum SCG. Finally, we showed that placing the 
sensor on a flexible silicon rubber sheet rather than directly on the skin does not reduce the 
accuracy of the measurements which could be an indication that the wearable SCG sensing 
device can be placed over one’s clothes without deteriorating its performance.  
Future work should include analyzing SCG signals obtained from placing the sensor 
on different fabrics to verify that the SCG wearable device can be placed over clothes. 
More locations should also be investigated to understand the relation of whole body 
vibrations to SCG. More subjects should be included in future studies to be able to leave 
more subjects out during the model training and hyperparameter tuning should be 
performed to minimize RMSE. Finally, the same approach used in this paper can be used 
to estimate other cardiac parameters such as left ventricular ejection time (LVET) which 
with PEP can provide us with a measure of changes in cardiac contractility. 
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CHAPTER 5. CONCLUSION AND FUTURE DIRECTION 
5.1 Conclusion 
The American Heart Association forecasts that by 2030, there will be a 46% increase 
in the number of HF patients and a 127% in healthcare costs associated with the diseases 
from today’s estimates. Consequently, it can be deduced that this increase will result in a 
shortage in the number of healthcare providers per patient. Therefore, there is a compelling 
need to transfer care from clinics to the homes of patients to increase accessibility and 
decrease the overall cost of care. This would allow care to be automatically optimized to 
the needs of the patient with proactive, feedback-controlled therapies, and would thereby 
reduce the burden on the healthcare system by reducing the need for costly reactive 
measures such as emergency room visits. 
The methods and algorithms developed and discussed in this work improve the 
robustness of STIs measured using BCG and SCG signals and therefore significantly 
improve out-of-clinic monitoring of heart failure patients. This work can also advance the 
understanding of basic physiology by providing a platform for easy, unobtrusive, and in 
some cases continuous, measurements of the mechanical parameters of the cardiovascular 
system. A lot of active research is ongoing with BCG and SCG as unobtrusive alternatives 
to echocardiography and ICG for monitoring the mechanical function of the heart. 
However, it is important to ensure that the research can cross from the experimental clinical 
to non-clinical domains while maintaining the same level of reliability. This was the 
motivation behind this work as this dissertation addresses many of the limitations 
preventing this transition into the non-clinical, uncontrolled settings through the use of both 
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novel algorithms and measurement modalities that can potentially improve the accuracy of 
cardiovascular parameters measured outside the clinics. 
5.2 Future Directions 
Various potential future research endeavors can stem from this research. First, 
working on developing affordable high bandwidth systems, with similar performance to 
the force plate used in this research, would enable the use of these systems at homes rather 
than in public places such as health centers and grocery stores. This would in turn facilitate 
the monitoring process by guaranteeing the patient’s ability to obtain multiple 
measurements throughout the day. 
   The models and algorithms developed in chapters 3 and 4 to detect misplacement 
and universally estimate PEP can be extended to other hemodynamic parameters, such as 
the left ventricular ejection time (LVET), which, with PEP, can provide a measure of 
changes in cardiac contractility. Additionally, these algorithms take into consideration the 
different physiological states the person may pass through during the day, but they do not 
consider the pathophysiological differences such as the changes that may occur in a 
patient’s condition. Therefore, since the end goal is to use these algorithms on BCG / SCG 
signals to monitor HF patients, they should be tested on a population of those patients, both 
in hospitals and at homes, to make sure they provide an analogous level of performance.  
 Finally, a known problem with BCG and SCG signals is the large inter-subject 
variability of the waveforms, which is why these signals have not been used yet for 
diagnosis, but can used for monitoring the cardiac health of each person individually, due 
to the low intra-subject variability in the signals over serial measurements. However, after 
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developing the universal regression model discussed in chapter 4, it is possible that this 
would bypass the inter-subject variability problem and could be leveraged as a step to 
enabling early detection of HF using BCG / SCG signals. To test for that, controlled 
experiments need to be run on healthy subjects and HF patients to determine if a model can 
be designed to distinguish between the two categories and assess patients with HF.  
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